Unnamed: 0,activity_comment,activity_id,assay_chembl_id,assay_description,assay_type,bao_endpoint,bao_format,bao_label,canonical_smiles,document_chembl_id,document_journal,document_year,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_type,standard_units,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,toid,type,units,uo_units,value
58000,,18062753,CHEMBL4013613,Bactericidal activity against methicillin-resistant Staphylococcus aureus EMRSA-15 assessed as time required to kill bacteria by >6 log10CFU/ml at 4 times MIC by Miles Misra dilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4011643,J Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,2993774,=,1,1,=,TIME,hr,24.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,24.0
58001,,18062783,CHEMBL4013629,Bactericidal activity against vancomycin-resistant Enterococcus faecalis NCTC 12201 assessed as time required to kill bacteria by <3 log10CFU/ml at 4 times MIC by Miles Misra dilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4011643,J Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,2993774,=,1,1,=,TIME,hr,24.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Time,hr,UO_0000032,24.0
58002,,18062784,CHEMBL4013630,Bactericidal activity against methicillin-resistant Staphylococcus aureus EMRSA-15 assessed as time required to kill bacteria by 3 log10CFU/ml at 4 times MIC by Miles Misra dilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4011643,J Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,2993774,=,1,1,=,TIME,hr,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,6.0
58003,,18136350,CHEMBL4029905,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4028820,Bioorg Med Chem Lett,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3008373,=,1,1,=,MIC,ug.mL-1,0.039,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.039
58004,,18136351,CHEMBL4029906,Antibacterial activity against Micrococcus luteus ATCC 10240 after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4028820,Bioorg Med Chem Lett,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3008373,=,1,1,=,MIC,ug.mL-1,0.078,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,0.078
58005,,18136352,CHEMBL4029907,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4028820,Bioorg Med Chem Lett,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3008373,=,1,1,=,MIC,ug.mL-1,0.078,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.078
58006,,18136353,CHEMBL4029908,Antibacterial activity against Enterococcus faecalis ATCC 51299 after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4028820,Bioorg Med Chem Lett,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3008373,=,1,1,=,MIC,ug.mL-1,0.156,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.156
58007,,18136354,CHEMBL4029909,Antibacterial activity against Bacillus subtilis ATCC 11774 after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4028820,Bioorg Med Chem Lett,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3008373,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.39
58008,,18136355,CHEMBL4029910,Antibacterial activity against Escherichia coli ATCC 10536 after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4028820,Bioorg Med Chem Lett,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3008373,=,1,1,=,MIC,ug.mL-1,0.078,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.078
58009,,18136356,CHEMBL4029911,Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4028820,Bioorg Med Chem Lett,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3008373,=,1,1,=,MIC,ug.mL-1,0.312,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.312
58010,,18136357,CHEMBL4029912,Antibacterial activity against Klebsiella pneumoniae ATCC BAA-2146 after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4028820,Bioorg Med Chem Lett,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3008373,=,1,1,=,MIC,ug.mL-1,2.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.5
58011,,18147436,CHEMBL4032600,Antibacterial activity against wild type Mycobacterium tuberculosis H37Rv grown in GAST/Fe medium measured on day 14 post inoculation by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4028901,J Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Micromolar,3010436,=,1,0,=,MIC99,uM,0.64,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC99,uM,UO_0000064,0.64
58012,,18147448,CHEMBL4032601,Antibacterial activity against 6-((3-Fluorobenzyl)(methyl)amino)-N-(4-methoxyphenyl)-pyrimidine-4-carboxamide-resisitant Mycobacterium tuberculosis H37Rv grown in GAST/Fe medium measured on day 14 post inoculation by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4028901,J Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Micromolar,3010436,=,1,0,=,MIC99,uM,1.3,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC99,uM,UO_0000064,1.3
58013,,18190389,CHEMBL4041589,Antitubercular activity against isoniazid resistant Mycobacterium tuberculosis H37Rv harboring KAtG Y155 deletion mutant after 5 days,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4041463,Eur J Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3017611,=,1,1,=,MIC,ug.mL-1,0.44,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.44
58014,,18190394,CHEMBL4041590,Antitubercular activity against isoniazid resistant Mycobacterium tuberculosis ATCC 35822 after 5 days,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4041463,Eur J Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3017611,=,1,1,=,MIC,ug.mL-1,0.59,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.59
58015,,18190399,CHEMBL4041591,Antitubercular activity against rifampicin resistant Mycobacterium tuberculosis H37Rv harboring rpoB S522L mutant after 5 days,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4041463,Eur J Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3017611,=,1,1,=,MIC,ug.mL-1,0.37,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.37
58016,,18190404,CHEMBL4041592,Antitubercular activity against rifampicin resistant Mycobacterium tuberculosis ATCC 35828 after 5 days,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4041463,Eur J Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3017611,=,1,1,=,MIC,ug.mL-1,0.63,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.63
58017,,18190409,CHEMBL4041593,Antitubercular activity against fluoroquinolone resistant Mycobacterium tuberculosis H37Rv harboring gyrB D94N mutant after 5 days,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4041463,Eur J Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3017611,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,10.0
58018,,18215875,CHEMBL4046882,Antibacterial activity against vancomycin-resistant Enterococcus faecium (10-984) assessed as inhibition of microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4043204,Bioorg Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3022427,>,1,1,>,MIC,ug.mL-1,50.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,50.0
58019,,18215884,CHEMBL4046883,Antibacterial activity against methicillin-resistant Staphylococcus aureus (14-2095) assessed as inhibition of microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4043204,Bioorg Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3022427,=,1,1,=,MIC,ug.mL-1,3.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,3.125
58020,,18215893,CHEMBL4046885,Antibacterial activity against linezolid-resistant Staphylococcus epidermidis (14-583) assessed as inhibition of microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4043204,Bioorg Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3022427,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,12.5
58021,,18215902,CHEMBL4046886,Antibacterial activity against linezolid-resistant Staphylococcus haemolyticus 2975 assessed as inhibition of microbial growth incubated for 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4043204,Bioorg Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3022427,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC,ug ml-1,UO_0000274,12.5
58022,,18215923,CHEMBL4046884,Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability incubated for 24 hrs by trypan blue staining based assay,A,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4043204,Bioorg Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3022427,=,1,1,=,IC50,ug.mL-1,293.16,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,IC50,ug ml-1,UO_0000274,293.16
58023,,18215934,CHEMBL4046887,"Selectivity index, ratio of IC50 for cytotoxicity against African green monkey Vero cells to MIC for antibacterial activity against methicillin-resistant Staphylococcus aureus (14-2095)",U,BAO_0000179,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4043204,Bioorg Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3022427,=,1,0,=,Selectivity Index,,93.81,CHEMBL612545,,Unchecked,,,Selectivity Index,,,93.81
58024,,18215954,CHEMBL4046888,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of mycobacterial growth incubated for 2 weeks by MABA method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4043204,Bioorg Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3022427,=,1,1,=,MIC,ug.mL-1,0.078,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.078
58025,,18215976,CHEMBL4046889,Antimycobacterial activity against isoniazid/rifampicin/ethambutol-resistant Mycobacterium tuberculosis G122 assessed as inhibition of mycobacterial growth incubated for 2 weeks by MABA method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4043204,Bioorg Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3022427,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,6.25
58026,,18215998,CHEMBL4046890,Antimycobacterial activity against isoniazid/rifampicin/streptomycin-resistant Mycobacterium tuberculosis G133 assessed as inhibition of mycobacterial growth incubated for 2 weeks by MABA method,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4043204,Bioorg Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3022427,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.56
58027,Not Determined,18216020,CHEMBL4046891,"Selectivity index, ratio of IC50 for cytotoxicity against African green monkey Vero cells to MIC for Mycobacterium tuberculosis H37Rv ATCC 27294",T,BAO_0000179,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4043204,Bioorg Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3022427,,1,0,,Selectivity Index,,,CHEMBL612545,,Unchecked,,,Selectivity Index,,,
58028,,18236836,CHEMBL4051382,Antibacterial activity against Escherichia coli MG1655 measured every 15 mins for 12 hrs,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4049433,J Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3026383,=,1,1,=,MIC,ug.mL-1,0.013,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.013
58029,,18245726,CHEMBL4053340,Antibacterial activity against Staphylococcus aureus ATCC 29213 infected in C57BL6 mouse cornea assessed as decrease in number of viable bacteria at 0.5% administered topically at 2 hrs interval for 4 times starting on day 1 post infection measured post last dose relative to control,F,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4052597,J Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3027672,=,1,0,=,Activity,%,99.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,99.2
58030,,18312052,CHEMBL4132287,Antitubercular activity against Mycobacterium tuberculosis INH-R1 harboring katG Y155 truncated mutant after 5 days by fluorescence-based assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4130372,Eur J Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3039894,=,1,1,=,MIC,nM,1100.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,1.1
58031,,18312060,CHEMBL4132288,Antitubercular activity against Mycobacterium tuberculosis INH-R2 ATCC 35822 after 5 days by fluorescence-based assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4130372,Eur J Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3039894,=,1,1,=,MIC,nM,1300.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,1.3
58032,,18312068,CHEMBL4132289,Antitubercular activity against Mycobacterium tuberculosis RIF-R1 harboring rpoB S522L mutant after 5 days by fluorescence-based assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4130372,Eur J Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3039894,=,1,1,=,MIC,nM,850.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.85
58033,,18312076,CHEMBL4132290,Antitubercular activity against Mycobacterium tuberculosis RIF-R2 ATCC 35828 after 5 days by fluorescence-based assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4130372,Eur J Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3039894,=,1,1,=,MIC,nM,1400.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,1.4
58034,,18312084,CHEMBL4132291,Antitubercular activity against Mycobacterium tuberculosis FQ-R1 harboring gyrB D94N mutant after 5 days by fluorescence-based assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4130372,Eur J Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3039894,=,1,1,=,MIC,nM,14000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,14.0
58035,,18330983,CHEMBL4136314,Antibacterial activity against Staphylococcus aureus ATCC 6538P by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4130562,ACS Med Chem Lett,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3043586,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58036,,18331011,CHEMBL4136315,Antibacterial activity against Staphylococcus aureus ATCC 33591 by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4130562,ACS Med Chem Lett,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3043586,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
58037,,18331039,CHEMBL4136316,Antibacterial activity against Staphylococcus aureus ATCC 29213 by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4130562,ACS Med Chem Lett,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3043586,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58038,,18331067,CHEMBL4136317,Antibacterial activity against methicillin-resistant Staphylococcus aureus 1201984 by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4130562,ACS Med Chem Lett,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3043586,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
58039,,18331095,CHEMBL4136318,Antibacterial activity against linezolid-resistant Staphylococcus aureus by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4130562,ACS Med Chem Lett,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3043586,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58040,,18331123,CHEMBL4136319,Antibacterial activity against Enterococcus faecalis ATCC 29212 by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4130562,ACS Med Chem Lett,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3043586,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.25
58041,,18331151,CHEMBL4136320,Antibacterial activity against Enterococcus faecium 19434 by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4130562,ACS Med Chem Lett,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3043586,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,4.0
58042,,18331179,CHEMBL4136321,Antibacterial activity against Streptococcus pneumoniae 55143 by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4130562,ACS Med Chem Lett,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3043586,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
58043,,18331207,CHEMBL4136322,Antibacterial activity against Streptococcus pyogenes ATCC 19615 by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4130562,ACS Med Chem Lett,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3043586,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.06
58044,,18331235,CHEMBL4136323,Antibacterial activity against Staphylococcus epidermidis ATCC 14990 by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4130562,ACS Med Chem Lett,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3043586,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.5
58045,,18331263,CHEMBL4136324,Antibacterial activity against Haemophilus influenzae ATCC 49247 by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4130562,ACS Med Chem Lett,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3043586,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.06
58046,,18362417,CHEMBL4142033,Antibacterial activity against Enterococcus faecalis NCTC 12697 after 16 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4138171,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3047787,=,1,1,=,MIC,nM,1400.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,uM,UO_0000065,1.4
58047,Not Determined,18362452,CHEMBL4142034,Antibacterial activity against Bacillus subtilis NCTC 10400 after 16 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4138171,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3047787,,1,0,,MIC,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,,,
58048,Not Determined,18362487,CHEMBL4142035,Antibacterial activity against methicillin-sensitive Staphylococcus aureus NCTC 12981 after 16 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4138171,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3047787,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
58049,Not Determined,18362522,CHEMBL4142036,Antibacterial activity against methicillin-resistant Staphylococcus aureus NCTC 13373 after 16 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4138171,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3047787,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
58050,,18362557,CHEMBL4142037,Antibacterial activity against Norfloxacin-resistant Staphylococcus aureus 1199B over-expressing NorA after 16 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4138171,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3047787,=,1,1,=,MIC,nM,5530.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,5.53
58051,,18362592,CHEMBL4142038,Antibacterial activity against erythromycin-resistant Staphylococcus aureus RN4220 after 16 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4138171,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3047787,=,1,1,=,MIC,nM,690.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.69
58052,Not Determined,18362627,CHEMBL4142039,Antibacterial activity against Staphylococcus aureus EMRSA-15 after 16 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4138171,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3047787,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
58053,Not Determined,18362662,CHEMBL4142040,Antibacterial activity against tetracycline/methicillin-resistant Staphylococcus aureus XU212 after 16 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4138171,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3047787,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
58054,,18387698,CHEMBL4147188,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4145491,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3051980,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
58055,,18387702,CHEMBL4147189,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4145491,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3051980,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
58056,,18399916,CHEMBL4149945,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4145598,ACS Med Chem Lett,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3053978,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
58057,,18399942,CHEMBL4149946,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus isolate 15 after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4145598,ACS Med Chem Lett,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3053978,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58058,,18399975,CHEMBL4149947,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus isolate 13-17 after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4145598,ACS Med Chem Lett,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3053978,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58059,,18400001,CHEMBL4149948,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus isolate 13-19 after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4145598,ACS Med Chem Lett,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3053978,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
58060,,18400027,CHEMBL4149949,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus isolate 13-20 after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4145598,ACS Med Chem Lett,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3053978,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58061,,18400053,CHEMBL4149950,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus isolate 13-21 after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4145598,ACS Med Chem Lett,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3053978,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
58062,,18400079,CHEMBL4149951,Antimicrobial activity against methicillin-sensitive Staphylococcus epidermidis ATCC 12228 after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4145598,ACS Med Chem Lett,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3053978,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.06
58063,,18400105,CHEMBL4149952,Antimicrobial activity against methicillin-sensitive Staphylococcus epidermidis isolate 13-1 after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4145598,ACS Med Chem Lett,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3053978,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
58064,,18400131,CHEMBL4149953,Antimicrobial activity against Staphylococcus saprophyticus ATCC 15305 after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4145598,ACS Med Chem Lett,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3053978,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC,ug ml-1,UO_0000274,0.5
58065,,18400157,CHEMBL4149954,Antimicrobial activity against Staphylococcus hominis ATCC 35982 after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4145598,ACS Med Chem Lett,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3053978,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC,ug ml-1,UO_0000274,0.125
58066,,18400183,CHEMBL4149955,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4145598,ACS Med Chem Lett,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3053978,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58067,,18400209,CHEMBL4149956,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate 13-18 after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4145598,ACS Med Chem Lett,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3053978,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58068,,18400235,CHEMBL4149957,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate 13-23 after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4145598,ACS Med Chem Lett,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3053978,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58069,,18400261,CHEMBL4149958,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate 12-3 after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4145598,ACS Med Chem Lett,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3053978,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58070,,18400287,CHEMBL4149959,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate 12-8 after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4145598,ACS Med Chem Lett,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3053978,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58071,,18400313,CHEMBL4149960,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate 12-13 after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4145598,ACS Med Chem Lett,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3053978,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58072,,18400339,CHEMBL4149961,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate 12-16 after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4145598,ACS Med Chem Lett,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3053978,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58073,,18400365,CHEMBL4149962,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC-BAA-1708 after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4145598,ACS Med Chem Lett,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3053978,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
58074,,18400391,CHEMBL4149963,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus ATCC 700698 after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4145598,ACS Med Chem Lett,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3053978,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58075,,18400417,CHEMBL4149964,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus ATCC 700699 after 18 hrs by agar dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4145598,ACS Med Chem Lett,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3053978,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
58076,,18457072,CHEMBL4179601,Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis H37Rv INH-R1 harboring katG Y155 mutant after 5 days,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4177599,Bioorg Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3063188,=,1,1,=,MIC,nM,1100.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,1.1
58077,,18457129,CHEMBL4179602,Antitubercular activity against rifampicin-resistant Mycobacterium tuberculosis H37Rv RIF-R1 harboring rpoB S522L mutant after 5 days,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4177599,Bioorg Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3063188,=,1,1,=,MIC,nM,850.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.85
58078,,18457186,CHEMBL4179603,Antitubercular activity against fluoroquinolone-resistant Mycobacterium tuberculosis H37Rv harboring gyrB D94N mutant after 5 days,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4177599,Bioorg Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3063188,=,1,1,=,MIC,nM,14000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,14.0
58079,,18457392,CHEMBL4179628,Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis INH-R2 ATCC 35822 after 5 days,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4177599,Bioorg Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3063188,=,1,1,=,MIC,nM,1300.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,1.3
58080,,18457449,CHEMBL4179629,Antitubercular activity against rifampicin-resistant Mycobacterium tuberculosis H37Rv RIF-R2 ATCC 35828 after 5 days,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4177599,Bioorg Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3063188,=,1,1,=,MIC,nM,1400.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,1.4
58081,,18518191,CHEMBL4193440,Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human erythrocytes after 72 hrs by SYBR Green-1 staining based fluorescence assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190314,Eur J Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3074753,>,1,1,>,IC50,nM,20000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,20000.0
58082,,18530080,CHEMBL4195105,Antibacterial activity against wild type Escherichia coli by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,32.0
58083,,18530081,CHEMBL4195104,Antibacterial activity against quinolone resistant Escherichia coli by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,32.0
58084,,18530082,CHEMBL4195106,Antibacterial activity against beta-lactam resistant Escherichia coli by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,32.0
58085,,18530083,CHEMBL4195107,Antibacterial activity against aminoglycoside resistant Escherichia coli by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,32.0
58086,,18530084,CHEMBL4195108,Antibacterial activity against multidrug resistant Escherichia coli by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,32.0
58087,,18530085,CHEMBL4195105,Antibacterial activity against wild type Escherichia coli by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,0.06
58088,,18530086,CHEMBL4195104,Antibacterial activity against quinolone resistant Escherichia coli by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,0.06
58089,,18530087,CHEMBL4195106,Antibacterial activity against beta-lactam resistant Escherichia coli by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,0.06
58090,,18530088,CHEMBL4195107,Antibacterial activity against aminoglycoside resistant Escherichia coli by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,0.06
58091,,18530089,CHEMBL4195108,Antibacterial activity against multidrug resistant Escherichia coli by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,0.06
58092,,18530090,CHEMBL4195105,Antibacterial activity against wild type Escherichia coli by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
58093,,18530091,CHEMBL4195104,Antibacterial activity against quinolone resistant Escherichia coli by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
58094,,18530092,CHEMBL4195106,Antibacterial activity against beta-lactam resistant Escherichia coli by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
58095,,18530093,CHEMBL4195107,Antibacterial activity against aminoglycoside resistant Escherichia coli by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
58096,,18530094,CHEMBL4195108,Antibacterial activity against multidrug resistant Escherichia coli by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
58097,,18530095,CHEMBL4195109,Antibacterial activity against wild type Acinetobacter baumannii by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC90,ug ml-1,UO_0000274,16.0
58098,,18530096,CHEMBL4195110,Antibacterial activity against aminoglycoside resistant Acinetobacter baumannii by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC90,ug ml-1,UO_0000274,16.0
58099,,18530097,CHEMBL4195111,Antibacterial activity against quinolone resistant Acinetobacter baumannii by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC90,ug ml-1,UO_0000274,16.0
58100,,18530098,CHEMBL4195112,Antibacterial activity against beta-lactam resistant Acinetobacter baumannii by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC90,ug ml-1,UO_0000274,16.0
58101,,18530099,CHEMBL4195113,Antibacterial activity against carbapenem resistant Acinetobacter baumannii by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC90,ug ml-1,UO_0000274,16.0
58102,,18530100,CHEMBL4195114,Antibacterial activity against multidrug resistant Acinetobacter baumannii by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC90,ug ml-1,UO_0000274,16.0
58103,,18530101,CHEMBL4195109,Antibacterial activity against wild type Acinetobacter baumannii by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC50,ug ml-1,UO_0000274,2.0
58104,,18530102,CHEMBL4195110,Antibacterial activity against aminoglycoside resistant Acinetobacter baumannii by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC50,ug ml-1,UO_0000274,2.0
58105,,18530103,CHEMBL4195111,Antibacterial activity against quinolone resistant Acinetobacter baumannii by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC50,ug ml-1,UO_0000274,2.0
58106,,18530104,CHEMBL4195112,Antibacterial activity against beta-lactam resistant Acinetobacter baumannii by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC50,ug ml-1,UO_0000274,2.0
58107,,18530105,CHEMBL4195113,Antibacterial activity against carbapenem resistant Acinetobacter baumannii by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC50,ug ml-1,UO_0000274,2.0
58108,,18530106,CHEMBL4195114,Antibacterial activity against multidrug resistant Acinetobacter baumannii by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC50,ug ml-1,UO_0000274,2.0
58109,,18530107,CHEMBL4195109,Antibacterial activity against wild type Acinetobacter baumannii by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.06
58110,,18530108,CHEMBL4195110,Antibacterial activity against aminoglycoside resistant Acinetobacter baumannii by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.06
58111,,18530109,CHEMBL4195111,Antibacterial activity against quinolone resistant Acinetobacter baumannii by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.06
58112,,18530110,CHEMBL4195112,Antibacterial activity against beta-lactam resistant Acinetobacter baumannii by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.06
58113,,18530111,CHEMBL4195113,Antibacterial activity against carbapenem resistant Acinetobacter baumannii by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.06
58114,,18530112,CHEMBL4195114,Antibacterial activity against multidrug resistant Acinetobacter baumannii by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4190388,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3076637,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.06
58115,,18588621,CHEMBL4223958,Antibacterial activity against clinical isolate of Staphylococcus aureus after 24 hrs by twofold microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4219240,Bioorg Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3087051,<,1,1,<,MIC,ug.mL-1,1.95,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.95
58116,,18588651,CHEMBL4223959,Antibacterial activity against clinical isolate of Escherichia coli after 24 hrs by twofold microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4219240,Bioorg Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3087051,<,1,1,<,MIC,ug.mL-1,1.95,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.95
58117,,18588681,CHEMBL4223960,Antifungal activity against Candida albicans CMCC (F) 98001 after 24 hrs by twofold microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4219240,Bioorg Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3087051,>,1,1,>,MIC,ug.mL-1,250.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,250.0
58118,,18659893,CHEMBL4231987,Antibacterial activity against Citrobacter freundii ATCC 43864 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,0.03
58119,,18659894,CHEMBL4231986,Antibacterial activity against Stenotrophomonas maltophilia ATCC 13636 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,0.25
58120,,18659895,CHEMBL4231985,Antibacterial activity against Proteus vulgaris ATCC 29905 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.125
58121,,18659896,CHEMBL4231984,Antibacterial activity against Providencia rettgeri ATCC 31052 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,MIC,ug ml-1,UO_0000274,0.03
58122,,18659897,CHEMBL4231983,Antibacterial activity against Serratia marcescens ATCC 21074 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.06
58123,,18659898,CHEMBL4231982,Antibacterial activity against Enterobacter aerogenes ATCC 13048 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.03
58124,,18659899,CHEMBL4231981,Antibacterial activity against Pseudomonas aeruginosa 12-16 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
58125,,18659900,CHEMBL4231980,Antibacterial activity against Pseudomonas aeruginosa PAO1 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
58126,,18659901,CHEMBL4231979,Antibacterial activity against extended-spectrum beta-lactamase deficient Klebsiella pneumoniae 12-4 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
58127,,18659902,CHEMBL4231978,Antibacterial activity against extended-spectrum beta-lactamase deficient Klebsiella pneumoniae 7 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
58128,,18659903,CHEMBL4231977,Antibacterial activity against extended-spectrum beta-lactamase deficient Escherichia coli 12-14 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
58129,,18659904,CHEMBL4231976,Antibacterial activity against extended-spectrum beta-lactamase deficient Escherichia coli 1515 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
58130,,18659905,CHEMBL4231975,Antibacterial activity against vancomycin-resistant Enterococcus faecium 12-1 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,32.0
58131,,18659906,CHEMBL4231974,Antibacterial activity against vancomycin-sensitive Enterococcus faecalis 12-5 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
58132,,18659907,CHEMBL4231973,Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51299 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
58133,,18659908,CHEMBL4231972,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 12-28 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58134,,18659909,CHEMBL4231971,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 15 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58135,,18659910,CHEMBL4231970,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58136,,18659911,CHEMBL4231969,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 12-6 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.5
58137,,18659912,CHEMBL4231968,Antibacterial activity against new delhi metallo-beta-lactamase-1 harboring Enterobacter cloacae 13-1 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,128.0
58138,,18659913,CHEMBL4231967,Antibacterial activity against new delhi metallo-beta-lactamase-1 harboring Enterobacter cloacae CDC1000654 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,32.0
58139,,18659914,CHEMBL4231966,Antibacterial activity against carbapenem-resistant Enterobacter aerogenes 11-4 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,16.0
58140,,18659915,CHEMBL4231965,Antibacterial activity against carbapenem-resistant Acinetobacter calcoaceticus 12-6 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC,ug ml-1,UO_0000274,8.0
58141,,18659916,CHEMBL4231964,Antibacterial activity against new delhi metallo-beta-lactamase-1 harboring Acinetobacter calcoaceticus 13-1 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC,ug ml-1,UO_0000274,2.0
58142,,18659917,CHEMBL4231963,Antibacterial activity against carbapenem-resistant Klebsiella pneumoniae 12-12 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
58143,,18659918,CHEMBL4231962,Antibacterial activity against carbapenem-resistant Klebsiella pneumoniae 12-11 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
58144,,18659919,CHEMBL4231961,Antibacterial activity against new delhi metallo-beta-lactamase-1 harboring Klebsiella pneumoniae 13-1 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
58145,,18659920,CHEMBL4231959,Antibacterial activity against extended-spectrum beta-lactamase harboring Escherichia coli 13-1 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
58146,,18659921,CHEMBL4231960,Antibacterial activity against extended-spectrum beta-lactamase harboring Escherichia coli CDC1001728 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
58147,,18659922,CHEMBL4231957,Antibacterial activity against Proteus mirabilis 12-6 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,4.0
58148,,18659923,CHEMBL4231956,Antibacterial activity against Enterobacter cloacae ATCC 43560 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.03
58149,,18659924,CHEMBL4231955,Antibacterial activity against Acinetobacter calcoaceticus ATCC 19606 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC,ug ml-1,UO_0000274,0.5
58150,,18659925,CHEMBL4231954,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
58151,,18659926,CHEMBL4231953,Antibacterial activity against extended-spectrum beta-lactamase harboring Klebsiella pneumoniae 12-8 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
58152,,18659927,CHEMBL4231952,Antibacterial activity against new delhi metallo-beta-lactamase-1 harboring Klebsiella pneumoniae ATCC BAA-2146 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,128.0
58153,,18659928,CHEMBL4231951,Antibacterial activity against extended-spectrum beta-lactamase harboring Klebsiella pneumoniae ATCC 700603 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.5
58154,,18659929,CHEMBL4231950,Antibacterial activity against extended-spectrum beta-lactamase harboring Escherichia coli 12-15 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
58155,,18659930,CHEMBL4231949,Antibacterial activity against extended-spectrum beta-lactamase deficient Escherichia coli ATCC 25922 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
58156,,18659931,CHEMBL4231948,Antibacterial activity against vancomycin-sensitive Enterococcus faecium 12-3 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,32.0
58157,,18659932,CHEMBL4231947,Antibacterial activity against vancomycin-resistant Enterococcus faecium ATCC 700221 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,64.0
58158,,18659933,CHEMBL4231946,Antibacterial activity against vancomycin-resistant Enterococcus faecalis 09-9 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,128.0
58159,,18659934,CHEMBL4231945,Antibacterial activity against vancomycin-sensitive Enterococcus faecalis ATCC 29212 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
58160,,18659935,CHEMBL4231944,Antibacterial activity against methicillin-resistant Staphylococcus aureus 12-33 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58161,,18659936,CHEMBL4231943,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58162,,18659937,CHEMBL4231942,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 12-8 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,4.0
58163,,18659938,CHEMBL4231941,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis ATCC 12228 after 18 hrs by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229379,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3099147,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
58164,,18673103,CHEMBL4235060,Antibacterial activity against Staphylococcus aureus SMITH after 18 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101428,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.1
58165,,18673111,CHEMBL4235061,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae J24 after 18 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101428,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.78
58166,,18673119,CHEMBL4235062,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae J41 after 18 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101428,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.56
58167,,18673127,CHEMBL4235063,Antibacterial activity against Streptococcus pyogenes ATCC 12344 after 18 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101428,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.39
58168,,18673135,CHEMBL4235064,Antibacterial activity against Enterococcus faecalis ATCC 19433 after 18 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101428,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.78
58169,,18673143,CHEMBL4235065,Antibacterial activity against Bacillus subtilis ATCC 6633 after 18 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101428,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,MIC,ug ml-1,UO_0000274,0.05
58170,,18673151,CHEMBL4235066,Antibacterial activity against Escherichia coli NIHJ after 18 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101428,=,1,1,=,MIC,ug.mL-1,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.012
58171,,18673159,CHEMBL4235067,Antibacterial activity against Klebsiella pneumoniae TYPE 1 after 18 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101428,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.05
58172,,18673167,CHEMBL4235068,Antibacterial activity against Haemophilus influenzae ATCC 49247 after 18 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101428,=,1,1,=,MIC,ug.mL-1,0.012,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.012
58173,,18673175,CHEMBL4235069,Antibacterial activity against Moraxella catarrhalis ATCC 25238 after 18 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101428,=,1,1,=,MIC,ug.mL-1,0.025,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC,ug ml-1,UO_0000274,0.025
58174,,18673183,CHEMBL4235070,Antibacterial activity against Pseudomonas aeruginosa PAO1 after 18 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101428,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.39
58175,,18673191,CHEMBL4235071,Antibacterial activity against levofloxacin and methicillin-resistant Staphylococcus aureus 870307 after 18 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101428,>,1,1,>,MIC,ug.mL-1,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,6.25
58176,,18673199,CHEMBL4235072,Antibacterial activity against levofloxacin and methicillin-resistant Staphylococcus aureus 890325-1 after 18 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101428,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,6.25
58177,,18673203,CHEMBL4235073,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 033806 after 18 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101428,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.56
58178,,18673211,CHEMBL4235074,Antibacterial activity against quinolone-resistant Escherichia coli DNS5101 after 18 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101428,>,1,1,>,MIC,ug.mL-1,6.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,6.25
58179,,18673219,CHEMBL4235075,Antibacterial activity against Escherichia coli 5-037042'98 harboring gyrase A Asp87Gly mutation after 18 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101428,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.1
58180,,18673223,CHEMBL4235076,Antibacterial activity against methicillin-resistant Staphylococcus aureus after 18 hrs by two-fold microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101428,>=,1,1,>=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
58181,,18673228,CHEMBL4235076,Antibacterial activity against methicillin-resistant Staphylococcus aureus after 18 hrs by two-fold microbroth dilution method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101428,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.5
58182,,18673233,CHEMBL4235076,Antibacterial activity against methicillin-resistant Staphylococcus aureus after 18 hrs by two-fold microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3101428,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,8.0
58183,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,18673272,CHEMBL4235085,"Cmax in Crj:CD rat at 5 mg/kg, po",A,BAO_0002119,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3101428,=,1,1,=,Cmax,nM,4067.85,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Cmax,ug ml-1,UO_0000065,1.47
58184,,18673278,CHEMBL4235086,"AUC (0 to 8 hrs) in Crj:CD rat at 5 mg/kg, po",A,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3101428,=,1,1,=,AUC,ng.hr.mL-1,3410.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,AUC,microg.hr/mL,,3.41
58185,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,18673281,CHEMBL4235087,"Cmax in cynomolgus monkey serum at 5 mg/kg, po",A,BAO_0002119,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3101428,=,1,1,=,Cmax,nM,5313.11,CHEMBL613847,Macaca fascicularis,Cynomolgus monkey,9541.0,,Cmax,ug ml-1,UO_0000065,1.92
58186,,18673285,CHEMBL4235088,"AUC (0 to 24 hrs) in cynomolgus monkey serum at 5 mg/kg, po",A,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3101428,=,1,1,=,AUC,ng.hr.mL-1,15200.0,CHEMBL613847,Macaca fascicularis,Cynomolgus monkey,9541.0,,AUC,microg.hr/mL,,15.2
58187,,18673289,CHEMBL4235089,"Half life in cynomolgus monkey serum at 5 mg/kg, po",A,BAO_0002115,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,3101428,=,1,1,=,T1/2,hr,3.5,CHEMBL613847,Macaca fascicularis,Cynomolgus monkey,9541.0,,t1/2,hr,UO_0000032,3.5
58188,,18673313,CHEMBL4235097,"AUC (0 to 8 hrs) in cynomolgus monkey serum at 10 mg/kg, iv",A,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3101428,=,1,1,=,AUC,ng.hr.mL-1,15500.0,CHEMBL613847,Macaca fascicularis,Cynomolgus monkey,9541.0,,AUC,microg.hr/mL,,15.5
58189,,18673314,CHEMBL4235098,"Primary phase half life in cynomolgus monkey serum at 10 mg/kg, iv",A,BAO_0002115,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4229492,J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,3101428,=,1,1,=,T1/2,hr,3.2,CHEMBL613847,Macaca fascicularis,Cynomolgus monkey,9541.0,,alphat1/2,hr,UO_0000032,3.2
58190,,18719992,CHEMBL4257882,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 14 days by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4257450,Medchemcomm,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3110075,=,1,1,=,MIC,ug.mL-1,2.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,2.5
58191,,18720036,CHEMBL4257886,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4257450,Medchemcomm,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3110075,=,1,1,=,MIC,ug.mL-1,0.078,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.078
58192,,18720038,CHEMBL4257887,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4257450,Medchemcomm,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3110075,=,1,1,=,MIC,ug.mL-1,0.039,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.039
58193,,18720040,CHEMBL4257888,Antibacterial activity against Bacillus subtilis ATCC 11774 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4257450,Medchemcomm,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3110075,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.39
58194,,18720042,CHEMBL4257889,Antibacterial activity against Micrococcus luteus ATCC 10240 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4257450,Medchemcomm,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3110075,=,1,1,=,MIC,ug.mL-1,0.078,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,0.078
58195,,18720044,CHEMBL4257890,Antibacterial activity against Enterococcus faecalis ATCC 51299 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4257450,Medchemcomm,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3110075,=,1,1,=,MIC,ug.mL-1,0.156,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.156
58196,,18720046,CHEMBL4257891,Antibacterial activity against Escherichia coli 10536 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4257450,Medchemcomm,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3110075,=,1,1,=,MIC,ug.mL-1,0.078,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.078
58197,,18720048,CHEMBL4257892,Antibacterial activity against Klebsiella pneumoniae ATCC BAA-2146 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4257450,Medchemcomm,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3110075,=,1,1,=,MIC,ug.mL-1,0.625,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.625
58198,,18720050,CHEMBL4257893,Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4257450,Medchemcomm,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3110075,=,1,1,=,MIC,ug.mL-1,0.312,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.312
58199,,18720052,CHEMBL4257894,Antimycobacterial activity against Mycobacterium smegmatis ATCC 607 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4257450,Medchemcomm,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3110075,=,1,1,=,MIC,ug.mL-1,0.156,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC,ug ml-1,UO_0000274,0.156
58200,,18747614,CHEMBL4263192,Antitubercular activity against Mycobacterium tuberculosis H37Rv after 2 weeks by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261563,Medchemcomm,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3114921,=,1,1,=,MIC,ug.mL-1,2.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,2.5
58201,,18747642,CHEMBL4263193,Antimycobacterial activity against Mycobacterium smegmatis after 72 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261563,Medchemcomm,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3114921,=,1,1,=,MIC,ug.mL-1,2.5,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC,ug ml-1,UO_0000274,2.5
58202,,18747649,CHEMBL4263196,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261563,Medchemcomm,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3114921,=,1,1,=,MIC,ug.mL-1,0.078,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.078
58203,,18747652,CHEMBL4263197,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261563,Medchemcomm,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3114921,=,1,1,=,MIC,ug.mL-1,0.039,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.039
58204,,18747655,CHEMBL4263198,Antibacterial activity against Micrococcus luteus ATCC 10240 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261563,Medchemcomm,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3114921,=,1,1,=,MIC,ug.mL-1,0.078,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,0.078
58205,,18747658,CHEMBL4263199,Antibacterial activity against Bacillus subtilis ATCC 11774 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261563,Medchemcomm,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3114921,=,1,1,=,MIC,ug.mL-1,0.39,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.39
58206,,18747661,CHEMBL4263200,Antibacterial activity against Escherichia coli ATCC 10536 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261563,Medchemcomm,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3114921,=,1,1,=,MIC,ug.mL-1,0.078,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.078
58207,,18747664,CHEMBL4263201,Antibacterial activity against Enterococcus faecalis ATCC 51299 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261563,Medchemcomm,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3114921,=,1,1,=,MIC,ug.mL-1,0.156,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.156
58208,,18747667,CHEMBL4263202,Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261563,Medchemcomm,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3114921,=,1,1,=,MIC,ug.mL-1,0.312,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.312
58209,,18747670,CHEMBL4263203,Antibacterial activity against Klebsiella pneumoniae ATCC BAA-2146 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261563,Medchemcomm,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3114921,=,1,1,=,MIC,ug.mL-1,0.625,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.625
58210,,18749751,CHEMBL4263577,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 16 to 18 hrs by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261585,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3115445,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58211,,18749787,CHEMBL4263578,Antibacterial activity against Escherichia coli ATCC 25922 after 16 to 18 hrs by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261585,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3115445,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
58212,,18749825,CHEMBL4263579,Antibacterial activity against Klebsiella pneumoniae ATCC BAA-1705 after 16 to 18 hrs by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261585,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3115445,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
58213,,18749861,CHEMBL4263580,Antibacterial activity against Acinetobacter baumannii BAA-1605 after 16 to 18 hrs by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261585,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3115445,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
58214,,18749899,CHEMBL4263581,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 16 to 18 hrs by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261585,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3115445,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
58215,,18750054,CHEMBL4263588,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261585,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3115445,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
58216,,18750059,CHEMBL4263589,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR119 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261585,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3115445,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
58217,,18750064,CHEMBL4263590,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR10129 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261585,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3115445,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
58218,,18750069,CHEMBL4263591,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR10198 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261585,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3115445,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58219,,18750074,CHEMBL4263592,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR10192 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261585,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3115445,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
58220,,18750079,CHEMBL4263593,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR10186 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261585,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3115445,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
58221,,18750084,CHEMBL4263594,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR10193 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261585,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3115445,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58222,,18750089,CHEMBL4263595,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR10194 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261585,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3115445,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
58223,,18750094,CHEMBL4263596,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR10191 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261585,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3115445,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58224,,18750099,CHEMBL4263597,Antibacterial activity against vancomycin-resistant Staphylococcus aureus VRS1 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261585,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3115445,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58225,,18750104,CHEMBL4263598,Antibacterial activity against vancomycin-resistant Staphylococcus aureus VRS4 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261585,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3115445,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
58226,,18750109,CHEMBL4263599,Antibacterial activity against vancomycin-resistant Staphylococcus aureus VRS12 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4261585,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3115445,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58227,,18783197,CHEMBL4270881,Antibiotic activity against methicillin-resistant Staphylococcus aureus isolate CAIRD116 by broth microdilution assay or Alamar blue dye based colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270487,J Nat Prod,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3121047,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
58228,,18783210,CHEMBL4270882,Antibiotic activity against methicillin-resistant Staphylococcus aureus isolate CAIRD142 by broth microdilution assay or Alamar blue dye based colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270487,J Nat Prod,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3121047,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
58229,,18783223,CHEMBL4270883,Antibiotic activity against methicillin-resistant Staphylococcus aureus isolate CAIRD148 by broth microdilution assay or Alamar blue dye based colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270487,J Nat Prod,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3121047,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
58230,,18793236,CHEMBL4273281,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis ATCC 12228 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,=,1,1,=,MIC90,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,ug ml-1,UO_0000274,0.125
58231,,18793253,CHEMBL4273284,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,=,1,1,=,MIC90,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.125
58232,,18793267,CHEMBL4273283,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,=,1,1,=,MIC90,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.125
58233,,18793281,CHEMBL4273282,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 13-3 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,ug ml-1,UO_0000274,4.0
58234,,18793292,CHEMBL4273285,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,1.0
58235,,18793306,CHEMBL4273286,Antibacterial activity against Enterococcus faecalis ATCC 51299 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,1.0
58236,,18793320,CHEMBL4273287,Antibacterial activity against Enterococcus faecium ATCC 700221 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,16.0
58237,,18793334,CHEMBL4273288,Antibacterial activity against Enterococcus faecium 13-7 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,64.0
58238,,18793348,CHEMBL4273289,Antibacterial activity against extended-spectrum beta-lactamase deficient Escherichia coli ATCC 25922 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,<=,1,1,<=,MIC90,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,0.03
58239,,18793362,CHEMBL4273290,Antibacterial activity against extended-spectrum beta-lactamase harboring Escherichia coli ATCC 35218 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,<=,1,1,<=,MIC90,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,0.03
58240,,18793376,CHEMBL4273291,Antibacterial activity against extended-spectrum beta-lactamase harboring Klebsiella pneumoniae ATCC 700603 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,0.5
58241,,18793390,CHEMBL4273292,Antibacterial activity against extended-spectrum beta-lactamase deficient Klebsiella pneumoniae 15-2 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,<=,1,1,<=,MIC90,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,0.03
58242,,18793404,CHEMBL4273293,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,2.0
58243,,18793418,CHEMBL4273294,Antibacterial activity against Acinetobacter calcoaceticus ATCC 19606 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,=,1,1,=,MIC90,ug.mL-1,0.125,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC90,ug ml-1,UO_0000274,0.125
58244,,18793432,CHEMBL4273295,Antibacterial activity against Enterobacter cloacae ATCC 43560 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,<=,1,1,<=,MIC90,ug.mL-1,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC90,ug ml-1,UO_0000274,0.03
58245,,18793446,CHEMBL4273296,Antibacterial activity against Enterobacter aerogenes ATCC 13048 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC90,ug ml-1,UO_0000274,0.06
58246,,18793460,CHEMBL4273297,Antibacterial activity against Serratia marcescens ATCC 21074 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,=,1,1,=,MIC90,ug.mL-1,0.125,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC90,ug ml-1,UO_0000274,0.125
58247,,18793474,CHEMBL4273298,Antibacterial activity against Morganella morganii ATCC 25830 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,<=,1,1,<=,MIC90,ug.mL-1,0.03,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC90,ug ml-1,UO_0000274,0.03
58248,,18793488,CHEMBL4273299,Antibacterial activity against Providencia rettgeri ATCC 31052 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,<=,1,1,<=,MIC90,ug.mL-1,0.03,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,MIC90,ug ml-1,UO_0000274,0.03
58249,,18793502,CHEMBL4273300,Antibacterial activity against Proteus vulgaris ATCC 29905 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,<=,1,1,<=,MIC90,ug.mL-1,0.03,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC90,ug ml-1,UO_0000274,0.03
58250,,18793516,CHEMBL4273301,Antibacterial activity against Proteus mirabilis 13-1 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,<=,1,1,<=,MIC90,ug.mL-1,0.03,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC90,ug ml-1,UO_0000274,0.03
58251,,18793530,CHEMBL4273302,Antibacterial activity against Stenotrophomonas maltophilia ATCC 13636 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC90,ug ml-1,UO_0000274,1.0
58252,,18793544,CHEMBL4273303,Antibacterial activity against extended-spectrum beta-lactamase harboring Citrobacter freundii ATCC 43864 after 18 to 24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270565,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3123111,<=,1,1,<=,MIC90,ug.mL-1,0.03,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC90,ug ml-1,UO_0000274,0.03
58253,,18806758,CHEMBL4275298,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270624,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3124846,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58254,,18806789,CHEMBL4275299,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 16-1 clinical isolate after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270624,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3124846,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58255,,18806816,CHEMBL4275300,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270624,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3124846,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58256,,18806843,CHEMBL4275301,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270624,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3124846,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58257,,18806870,CHEMBL4275302,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC BAA-976 after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270624,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3124846,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58258,,18806897,CHEMBL4275303,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC BAA-1708 after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270624,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3124846,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
58259,,18806924,CHEMBL4275304,Antibacterial activity against methicillin-resistant Staphylococcus aureus 13-18 clinical isolate after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270624,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3124846,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58260,,18806951,CHEMBL4275305,Antibacterial activity against methicillin-resistant Staphylococcus aureus 13-23 clinical isolate after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270624,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3124846,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58261,,18806978,CHEMBL4275306,Antibacterial activity against methicillin-resistant Staphylococcus aureus 16-30 clinical isolate after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270624,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3124846,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58262,,18807005,CHEMBL4275307,Antibacterial activity against methicillin-resistant Staphylococcus aureus 16-34 clinical isolate after 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4270624,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3124846,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58263,,18829101,CHEMBL4303805,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4303101,,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3135599,=,52,1,=,Inhibition,%,13.51,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,Inhibition,%,UO_0000187,13.51
58264,,18903492,CHEMBL4316934,Antibacterial activity against methicillin-sensitive Staphylococcus aureus after 18 to 20 hrs by CLSI-protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4316588,J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154001,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,4.0
58265,,18903517,CHEMBL4316935,Antibacterial activity against methicillin-resistant Staphylococcus aureus after 18 to 20 hrs by CLSI-protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4316588,J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154001,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,16.0
58266,,18903563,CHEMBL4316936,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis after 18 to 20 hrs by CLSI-protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4316588,J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154001,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,mg/L,UO_0000274,0.5
58267,,18903608,CHEMBL4316937,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis after 18 to 20 hrs by CLSI-protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4316588,J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154001,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,mg/L,UO_0000274,4.0
58268,,18903653,CHEMBL4316938,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae after 18 to 20 hrs by CLSI-protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4316588,J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154001,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,mg/L,UO_0000274,1.0
58269,,18903698,CHEMBL4316939,Antibacterial activity against Streptococcus pyogenes after 18 to 20 hrs by CLSI-protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4316588,J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154001,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,mg/L,UO_0000274,0.5
58270,,18923540,CHEMBL4324086,Antimicrobial activity against Bacillus subtilis NCIM-2063 assessed as reduction in microbial growth after 24 hrs by CLSI based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4321839,Eur J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3156948,=,1,1,=,MIC,ug.mL-1,3.125,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,3.125
58271,,18923549,CHEMBL4324087,Antimicrobial activity against Escherichia coli NCIM-2065 assessed as reduction in microbial growth after 24 hrs by CLSI based broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4321839,Eur J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3156948,=,1,1,=,MIC,ug.mL-1,3.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,3.125
58272,,18923563,CHEMBL4324090,Antimicrobial activity against Staphylococcus aureus NCIM-2079 assessed as zone of inhibition at 5 ug after 24 hrs by disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4321839,Eur J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,3156948,=,1,1,=,IZ,mm,14.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,14.0
58273,,18923568,CHEMBL4324091,Antimicrobial activity against Bacillus subtilis NCIM-2063 assessed as zone of inhibition at 5 ug after 24 hrs by disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4321839,Eur J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,3156948,=,1,1,=,IZ,mm,14.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,IZ,mm,UO_0000016,14.0
58274,,19001069,CHEMBL4343532,Antimicrobial activity against Escherichia coli assessed as zone of inhibition at 0.001 mol/cm3,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,3170503,=,1,1,=,IZ,mm,28.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,28.0
58275,,19001070,CHEMBL4343533,Antimicrobial activity against Staphylococcus aureus assessed as zone of inhibition at 0.001 mol/cm3,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,3170503,=,1,1,=,IZ,mm,28.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,28.0
58276,,19001071,CHEMBL4343534,Antimicrobial activity against Bacillus cereus assessed as zone of inhibition at 0.001 mol/cm3,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4342421,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,3170503,=,1,1,=,IZ,mm,28.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,IZ,mm,UO_0000016,28.0
58277,,19051555,CHEMBL4354950,Antitubercular activity against resistant Mycobacterium tuberculosis harboring gyrA Asp94His mutant incubated for 28 days by absolute concentration method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4354781,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178393,>,1,1,>,MIC,ug.mL-1,10.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,10.0
58278,,19051556,CHEMBL4354951,Antitubercular activity against resistant Mycobacterium tuberculosis harboring gyrA Asp94Asn mutant incubated for 28 days by absolute concentration method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4354781,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178393,>,1,1,>,MIC,ug.mL-1,10.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,10.0
58279,,19051557,CHEMBL4354952,Antitubercular activity against resistant Mycobacterium tuberculosis harboring gyrA Asp94Gly mutant incubated for 28 days by absolute concentration method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4354781,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178393,>,1,1,>,MIC,ug.mL-1,10.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,10.0
58280,,19051558,CHEMBL4354953,Antitubercular activity against resistant Mycobacterium tuberculosis harboring gyrA Asp94Tyr mutant incubated for 28 days by absolute concentration method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4354781,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178393,>,1,1,>,MIC,ug.mL-1,10.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,10.0
58281,,19051559,CHEMBL4354954,Antitubercular activity against resistant Mycobacterium tuberculosis harboring gyrB Ala90Val mutant incubated for 28 days by absolute concentration method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4354781,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178393,>,1,1,>,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.0
58282,,19051560,CHEMBL4354955,Antitubercular activity against resistant Mycobacterium tuberculosis harboring gyrB T511N mutant incubated for 28 days by absolute concentration method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4354781,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178393,>,1,1,>,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.0
58283,,19051775,CHEMBL4355016,Toxicity in human assessed as arthralgia effect,T,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3178408,=,1,0,=,Activity,%,0.5,CHEMBL612558,,ADMET,,,Activity,%,UO_0000187,0.5
58284,,19051778,CHEMBL4355018,Toxicity in human assessed as CNS effect by measuring alteration in mentation,T,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4354782,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3178408,=,1,0,=,Activity,%,0.026,CHEMBL612558,,ADMET,,,Activity,%,UO_0000187,0.026
58285,,19066726,CHEMBL4360570,Antibacterial activity against methicillin sensitive Staphylococcus aureus NCTC 6571 measured after overnight incubation by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359823,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181130,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
58286,,19066756,CHEMBL4360571,Antibacterial activity against methicillin resistant Staphylococcus aureus NCTC13616 measured after overnight incubation by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359823,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181130,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
58287,,19066786,CHEMBL4360572,Antibacterial activity against methicillin resistant Staphylococcus aureus NCTC13277 measured after overnight incubation by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359823,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181130,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
58288,,19066816,CHEMBL4360573,Antibacterial activity against vancomycin sensitive Enterococcus faecalis NCTC775 measured after overnight incubation by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359823,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181130,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
58289,,19066858,CHEMBL4360569,Antibacterial activity against vancomycin resistant Enterococcus faecalis NCTC12201 measured after overnight incubation by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359823,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181130,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
58290,,19066900,CHEMBL4360568,Antibacterial activity against vancomycin resistant Enterococcus faecalis NCTC12204 measured after overnight incubation by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359823,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181130,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
58291,,19066941,CHEMBL4360574,Antibacterial activity against Klebsiella pneumoniae NCTC13368 measured after overnight incubation by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359823,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181130,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
58292,,19066970,CHEMBL4360575,Antibacterial activity against Klebsiella pneumoniae M6 measured after overnight incubation by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359823,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181130,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.12
58293,,19066999,CHEMBL4360576,Antibacterial activity against Acinetobacter baumannii AYE measured after overnight incubation by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359823,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181130,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
58294,,19067028,CHEMBL4360577,Antibacterial activity against Acinetobacter baumannii ATCC 17978 measured after overnight incubation by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359823,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181130,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.12
58295,,19067057,CHEMBL4360578,Antibacterial activity against Pseudomonas aeruginosa PAO1 measured after overnight incubation by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359823,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181130,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
58296,,19067086,CHEMBL4360579,Antibacterial activity against Pseudomonas aeruginosa NCTC13437 measured after overnight incubation by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359823,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181130,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
58297,,19067114,CHEMBL4360580,Antibacterial activity against Escherichia coli NCTC12923 measured after overnight incubation by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359823,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181130,<,1,1,<,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
58298,,19067220,CHEMBL4360602,Inhibition of Staphylococcus aureus DNA gyrase subunit A2B2 using relaxed pBR322 DNA as substrate measured after 30 mins in presence of ATP by ethidium bromide-based gel electrophoresis,B,BAO_0000190,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359823,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181130,=,1,1,=,IC50,ug.mL-1,8.71,CHEMBL612545,,Unchecked,,,IC50,ug ml-1,UO_0000274,8.71
58299,,19067224,CHEMBL4360603,Inhibition of Staphylococcus aureus DNA gyrase S84L mutant,B,BAO_0000190,BAO_0000223,protein complex format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359823,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181130,=,1,1,=,IC50,ug.mL-1,196.9,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,IC50,ug ml-1,UO_0000274,196.9
58300,,19067228,CHEMBL4360604,Inhibition of Staphylococcus aureus topoisomerase-4 expressed in Escherichia coli assessed as relaxation of pBR322 substrate measured after 4 hrs by SDS-PAGE,B,BAO_0000190,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359823,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181130,=,1,1,=,IC50,ug.mL-1,3.65,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,IC50,ug ml-1,UO_0000274,3.65
58301,,19067232,CHEMBL4360605,Antibacterial activity against Staphylococcus aureus NCTC13616 assessed as generation of drug resistance at 2 times MIC measured after 48 hrs by agar-based microbroth dilution method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359823,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3181130,=,1,0,=,Activity,,1.87e-06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,1.87e-06
58302,,19067236,CHEMBL4360606,Antibacterial activity against Staphylococcus aureus NCTC12204 assessed as generation of drug resistance at 2 times MIC measured after 48 hrs by agar-based microbroth dilution method,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359823,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3181130,=,1,0,=,Activity,,7.08e-07,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,7.08e-07
58303,,19081364,CHEMBL4363699,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 assessed as growth inhibition measured after 24 hrs by two-fold broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359915,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3183473,=,1,1,=,MIC,nM,11000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mmol/L,UO_0000065,0.011
58304,,19081385,CHEMBL4363700,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as growth inhibition measured after 24 hrs by two-fold broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359915,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3183473,=,1,1,=,MIC,nM,22000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mmol/L,UO_0000065,0.022
58305,,19081406,CHEMBL4363701,Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as growth inhibition measured after 24 hrs by two-fold broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359915,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3183473,=,1,1,=,MIC,nM,11000.0,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,MIC,mmol/L,UO_0000065,0.011
58306,,19081428,CHEMBL4363702,Antibacterial activity against Escherichia coli JM 109 assessed as growth inhibition measured after 24 hrs by two-fold broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359915,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3183473,=,1,1,=,MIC,nM,11000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mmol/L,UO_0000065,0.011
58307,,19081450,CHEMBL4363703,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 assessed as growth inhibition measured after 24 hrs by two-fold broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359915,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3183473,=,1,1,=,MIC,nM,3000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mmol/L,UO_0000065,0.003
58308,,19081513,CHEMBL4363713,Antibacterial activity against Bacillus proteus ATCC 8427 assessed as growth inhibition measured after 24 hrs by two-fold broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4359915,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3183473,=,1,1,=,MIC,nM,5000.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,mmol/L,UO_0000065,0.005
58309,,19088746,CHEMBL4365273,Antibacterial activity against Escherichia coli ATCC 25922 assessed as growth inhibition incubated for 18 to 24 hrs by broth microdilution based antibiotic susceptibility testing method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4364263,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3184609,<,1,1,<,MIC,nM,30000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM/ml,UO_0000065,0.03
58310,,19088752,CHEMBL4365281,Antibacterial activity against Klebsiella pneumoniae BAA-1705 assessed as growth inhibition incubated for 18 to 24 hrs by broth microdilution based antibiotic susceptibility testing method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4364263,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3184609,=,1,1,=,MIC,nM,64000000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,uM/ml,UO_0000065,64.0
58311,,19088758,CHEMBL4365282,Antibacterial activity against Acinetobacter baumannii BAA-1605 assessed as growth inhibition incubated for 18 to 24 hrs by broth microdilution based antibiotic susceptibility testing method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4364263,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3184609,=,1,1,=,MIC,nM,8000000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM/ml,UO_0000065,8.0
58312,,19088764,CHEMBL4365283,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as growth inhibition incubated for 18 to 24 hrs by broth microdilution based antibiotic susceptibility testing method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4364263,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3184609,=,1,1,=,MIC,nM,1000000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM/ml,UO_0000065,1.0
58313,,19088770,CHEMBL4365284,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as growth inhibition incubated for 18 to 24 hrs by broth microdilution based antibiotic susceptibility testing method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4364263,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3184609,=,1,1,=,MIC,nM,250000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM/ml,UO_0000065,0.25
58314,,19196698,CHEMBL4390608,Antibacterial activity against methicillin-resistant Staphylococcus aureus 16-30 assessed as prevention of visible bacterial growth incubated for 18 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4387792,J Nat Prod,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3204262,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58315,,19196704,CHEMBL4390607,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as prevention of visible bacterial growth incubated for 18 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4387792,J Nat Prod,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3204262,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
58316,,19196777,CHEMBL4390612,Antibacterial activity against vancomycin-resistant Enterococcus faecium 12-1 assessed as prevention of visible bacterial growth incubated for 18 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4387792,J Nat Prod,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3204262,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,128.0
58317,,19196783,CHEMBL4390611,Antibacterial activity against vancomycin-resistant Enterococcus faecium ATCC 700221 assessed as prevention of visible bacterial growth incubated for 18 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4387792,J Nat Prod,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3204262,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,128.0
58318,,19196789,CHEMBL4390610,Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51575 assessed as prevention of visible bacterial growth incubated for 18 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4387792,J Nat Prod,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3204262,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
58319,,19196795,CHEMBL4390609,Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51299 assessed as prevention of visible bacterial growth incubated for 18 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4387792,J Nat Prod,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3204262,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
58320,,19224799,CHEMBL4395782,Antibacterial activity against Staphylococcus aureus ATCC 29213 incubated for 16 to 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3209019,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58321,,19224866,CHEMBL4395783,Antibacterial activity against Escherichia coli ATCC 25922 incubated for 16 to 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3209019,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
58322,,19224929,CHEMBL4395765,Antibacterial activity against Klebsiella pneumoniae ATCC BAA-1705 incubated for 16 to 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3209019,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
58323,,19224992,CHEMBL4395764,Antibacterial activity against Acinetobacter baumannii BAA1605 incubated for 16 to 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3209019,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
58324,,19225055,CHEMBL4395784,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 16 to 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3209019,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
58325,Not Determined,19225118,CHEMBL4395785,Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 days by resazurin dye based assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3209019,,1,0,,MIC,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,,,
58326,,19225137,CHEMBL4395788,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 incubated for 16 to 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3209019,<,1,1,<,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
58327,,19225142,CHEMBL4395777,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR100 incubated for 16 to 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3209019,<,1,1,<,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
58328,,19225147,CHEMBL4395779,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR119 incubated for 16 to 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3209019,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
58329,,19225152,CHEMBL4395780,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR10129 incubated for 16 to 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3209019,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
58330,,19225157,CHEMBL4395781,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR10198 incubated for 16 to 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3209019,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58331,,19225162,CHEMBL4395778,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR10192 incubated for 16 to 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3209019,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
58332,,19225167,CHEMBL4395776,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR10186 incubated for 16 to 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3209019,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
58333,,19225172,CHEMBL4395775,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR10193 incubated for 16 to 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3209019,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58334,,19225177,CHEMBL4395773,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR10194 incubated for 16 to 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3209019,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
58335,,19225182,CHEMBL4395774,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR10191 incubated for 16 to 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3209019,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
58336,,19225187,CHEMBL4395772,Antibacterial activity against vancomycin-resistant Staphylococcus aureus VRS1 incubated for 16 to 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3209019,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58337,,19225192,CHEMBL4395771,Antibacterial activity against vancomycin-resistant Staphylococcus aureus VRS4 incubated for 16 to 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3209019,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
58338,,19225197,CHEMBL4395770,Antibacterial activity against vancomycin-resistant Staphylococcus aureus VRS12 incubated for 16 to 18 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3209019,>=,1,1,>=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58339,,19225291,CHEMBL4395830,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as time required to increase 1 log10 CFU at MIC incubated for 1 hr followed by compound washout and measured at 1 hr intervals (Rvb = 2 hrs),F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,3209019,=,1,1,=,TIME,hr,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,3.0
58340,,19225294,CHEMBL4395831,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as time required to increase 1 log10 CFU at 10 times MIC incubated for 1 hr followed by compound washout and measured at 1 hr intervals (Rvb = 2 hrs),F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,3209019,=,1,1,=,TIME,hr,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,3.0
58341,,19225297,CHEMBL4395832,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as post antibiotic effect time at MIC incubated for 1 hr followed by compound washout and measured at 1 hr intervals (Rvb = 0 hrs),F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,3209019,=,1,1,=,TIME,hr,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,1.0
58342,,19225300,CHEMBL4395833,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as post antibiotic effect time at 10 times MIC incubated for 1 hr followed by compound washout and measured at 1 hr intervals (Rvb = 0 hrs),F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,3209019,=,1,1,=,TIME,hr,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,1.0
58343,,19225303,CHEMBL4395834,Antibiofilm activity against Staphylococcus aureus ATCC 29213 at 10 times MIC incubated 48 hrs by crystal violet staining based assay relative to control,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4393707,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3209019,=,1,0,=,Activity,%,30.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,30.6
58344,,19308223,CHEMBL4415674,Antimicrobial activity against Staphylococcus aureus ATCC 29213,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4414576,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3224138,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
58345,,19308229,CHEMBL4415675,Antimicrobial activity against Streptococcus pneumoniae ATCC 49619,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4414576,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3224138,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
58346,,19366430,CHEMBL4423980,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4422644,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3241318,<,1,1,<,MIC,nM,30.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.03
58347,,19366465,CHEMBL4423981,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4422644,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3241318,=,1,1,=,MIC,nM,250.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.25
58348,,19366500,CHEMBL4423982,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4422644,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3241318,=,1,1,=,MIC,nM,1000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,1.0
58349,,19366535,CHEMBL4423983,Antibacterial activity against Klebsiella pneumoniae ATCC BAA-1705 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4422644,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3241318,=,1,1,=,MIC,nM,64000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,uM,UO_0000065,64.0
58350,,19366570,CHEMBL4423984,Antibacterial activity against Acinetobacter baumannii ATCC BAA-1605 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4422644,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3241318,=,1,1,=,MIC,nM,8000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM,UO_0000065,8.0
58351,,19366605,CHEMBL4423985,Antibacterial activity against Mycobacterium fortuitum after 7 days by alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4422644,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3241318,<,1,1,<,MIC,nM,30.0,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,MIC,uM,UO_0000065,0.03
58352,,19366640,CHEMBL4423986,Antibacterial activity against Mycobacterium chelonae after 7 days by alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4422644,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3241318,=,1,1,=,MIC,nM,250.0,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,MIC,uM,UO_0000065,0.25
58353,,19366675,CHEMBL4423987,Antibacterial activity against Mycobacterium abscessus after 7 days by alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4422644,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3241318,=,1,1,=,MIC,nM,64000.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,MIC,uM,UO_0000065,64.0
58354,,19370614,CHEMBL4424810,Antimicrobial activity against AcrB deficient Escherichia coli,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4422685,Bioorg Med Chem Lett,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3242185,=,1,1,=,MIC,ug.mL-1,0.063,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.063
58355,,19406533,CHEMBL4426544,Antimicrobial activity against Staphylococcus aureus isogenic forms expressing gyrA S84L mutant,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243526,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
58356,,19406537,CHEMBL4426546,Antimicrobial activity against wild type Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243526,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
58357,,19406543,CHEMBL4426549,Antimicrobial activity against Staphylococcus aureus isogenic forms expressing parC S80F mutant,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243526,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
58358,,19406549,CHEMBL4426551,Antimicrobial activity against Staphylococcus aureus isogenic forms expressing gyrA S84L and parC S80F mutant,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243526,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
58359,,19406555,CHEMBL4426554,Antimicrobial activity against Staphylococcus aureus isogenic forms expressing rpoB H481Y mutant,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243526,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
58360,,19406561,CHEMBL4426557,Antimicrobial activity against Staphylococcus aureus isogenic forms expressing rpoB H481Y and gyrA S84L mutant,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243526,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
58361,,19406567,CHEMBL4426560,Antimicrobial activity against Staphylococcus aureus isogenic forms expressing rpoB H481Y and parC S80F mutant,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243526,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
58362,,19406573,CHEMBL4426563,Antimicrobial activity against Staphylococcus aureus isogenic forms expressing rpoB H481Y/gyrA S84L/parC S80F mutant,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243526,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
58363,,19406627,CHEMBL4426597,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 67-0,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3243526,=,1,1,=,MIC,ug.mL-1,2000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/ml,UO_0000274,2.0
58364,,19406632,CHEMBL4426598,Bactericidal activity against methicillin-resistant Staphylococcus aureus 67-0,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4425125,J Med Chem,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3243526,=,1,0,=,MBC,mg/ml,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,mg/ml,,2.0
58365,,19410595,CHEMBL4427460,Antitubercular activity against Mycobacterium tuberculosis H37Rv FQ-R1 harboring gyrB D94N mutant after 5 days,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4425168,ACS Med Chem Lett,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3244349,=,1,1,=,MIC,nM,20000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,20.0
58366,,19410603,CHEMBL4427459,Antitubercular activity against Mycobacterium tuberculosis H37Rv RIF-R2 ATCC 35828 after 5 days,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4425168,ACS Med Chem Lett,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3244349,=,1,1,=,MIC,nM,1100.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,1.1
58367,,19410611,CHEMBL4427458,Antitubercular activity against Mycobacterium tuberculosis H37Rv RIF-R1 harboring nrpoB S522L mutant after 5 days,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4425168,ACS Med Chem Lett,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3244349,=,1,1,=,MIC,nM,760.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.76
58368,,19410619,CHEMBL4427457,Antitubercular activity against Mycobacterium tuberculosis H37Rv INH-R2 ATCC 35822 after 5 days,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4425168,ACS Med Chem Lett,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3244349,=,1,1,=,MIC,nM,1400.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,1.4
58369,,19410627,CHEMBL4427456,Antitubercular activity against Mycobacterium tuberculosis H37Rv INH-R1 harboring katG Y155 mutant after 5 days,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4425168,ACS Med Chem Lett,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3244349,=,1,1,=,MIC,nM,1200.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,1.2
58370,,19410690,CHEMBL4427456,Antitubercular activity against Mycobacterium tuberculosis H37Rv INH-R1 harboring katG Y155 mutant after 5 days,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4425168,ACS Med Chem Lett,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3244349,=,1,1,=,IC50,nM,640.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,IC50,uM,UO_0000065,0.64
58371,,19410706,CHEMBL4427457,Antitubercular activity against Mycobacterium tuberculosis H37Rv INH-R2 ATCC 35822 after 5 days,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4425168,ACS Med Chem Lett,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3244349,=,1,1,=,IC50,nM,840.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,IC50,uM,UO_0000065,0.84
58372,,19410722,CHEMBL4427458,Antitubercular activity against Mycobacterium tuberculosis H37Rv RIF-R1 harboring nrpoB S522L mutant after 5 days,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4425168,ACS Med Chem Lett,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3244349,=,1,1,=,IC50,nM,590.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,IC50,uM,UO_0000065,0.59
58373,,19410738,CHEMBL4427459,Antitubercular activity against Mycobacterium tuberculosis H37Rv RIF-R2 ATCC 35828 after 5 days,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4425168,ACS Med Chem Lett,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3244349,=,1,1,=,IC50,nM,600.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,IC50,uM,UO_0000065,0.6
58374,,19410754,CHEMBL4427460,Antitubercular activity against Mycobacterium tuberculosis H37Rv FQ-R1 harboring gyrB D94N mutant after 5 days,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4425168,ACS Med Chem Lett,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3244349,=,1,1,=,IC50,nM,12000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,IC50,uM,UO_0000065,12.0
58375,,19955528,CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20M  by FRET kind of response from peptide substrate,F,BAO_0000201,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4495564,,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3341946,=,52,1,=,Inhibition,%,93.65,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,Inhibition,%,UO_0000187,93.65
58376,,19960093,CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20M  by FRET kind of response from peptide substrate,F,BAO_0000201,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4495564,,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3346511,=,52,1,=,Inhibition,%,22.85,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,Inhibition,%,UO_0000187,22.85424438
58377,Ic50 Mers 3Cl-Pro,19964316,CHEMBL4495584,MERS_3CL Pro protease inhibition IC50  by FRET kind of response from peptide substrate,F,BAO_0000190,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4495564,,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3341946,=,52,1,=,IC50,nM,7600.0,CHEMBL4295557,Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (Betacoronavirus England 1) (Humancoronavirus EMC),Replicase polyprotein 1ab,1263720.0,,IC50,uM,UO_0000065,7.6
58378,,20150295,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4495565,,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3359818,=,52,1,=,Inhibition,%,0.12,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,0.12
58379,,20150877,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4495565,,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3364383,=,52,1,=,Inhibition,%,-0.06,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,-0.06
58380,Not Active,20154999,CHEMBL4513102,Growth inhibiting activity of Naegleria gruberi in vitro,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513101,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3368514,,34,1,,Inhibition,%,0.0,CHEMBL4543332,Naegleria gruberi,Naegleria gruberi,5762.0,,Inhibition,%,UO_0000187,0.0
58381,Median N= 2; Maxinhib 4.8 Pct,20163230,CHEMBL4296189,"Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513141,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3370063,>,40,1,>,MIC,nM,10000.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,uM,UO_0000065,10.0
58382,Median N= 2; Maxinhib 6.8 Pct,20163231,CHEMBL4296190,"Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570)",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513141,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3370063,>,40,1,>,MIC,nM,10000.0,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,MIC,uM,UO_0000065,10.0
58383,Median N= 2,20163232,CHEMBL4296185,"Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513141,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3370063,<=,40,1,<=,MIC,nM,78.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.0781
58384,Median N= 2,20163233,CHEMBL4296186,"Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513141,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3370063,=,40,1,=,MIC,nM,2500.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,uM,UO_0000065,2.5
58385,Median N= 2,20163234,CHEMBL4296187,"Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513141,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3370063,=,40,1,=,MIC,nM,625.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,0.625
58386,Median N= 2,20163235,CHEMBL4296188,"Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513141,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3370063,=,40,1,=,MIC,nM,2500.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM,UO_0000065,2.5
58387,Median N= 2,20163236,CHEMBL4296184,"Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513141,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3370063,=,40,1,=,MIC,nM,625.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.625
58388,Median N= 2; Maxinhib 1.7 Pct,20183180,CHEMBL4296189,"Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513149,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3372884,>,40,1,>,MIC,nM,10000.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,uM,UO_0000065,10.0
58389,Median N= 2; Maxinhib 38.6 Pct,20183181,CHEMBL4296190,"Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570)",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513149,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3372884,>,40,1,>,MIC,nM,10000.0,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,MIC,uM,UO_0000065,10.0
58390,Median N= 2,20183182,CHEMBL4296185,"Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513149,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3372884,<=,40,1,<=,MIC,nM,78.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.0781
58391,Median N= 2,20183183,CHEMBL4296186,"Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513149,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3372884,=,40,1,=,MIC,nM,2500.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,uM,UO_0000065,2.5
58392,Median N= 2; Range 1.25 - 0.625  Um,20183184,CHEMBL4296187,"Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513149,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3372884,=,40,1,=,MIC,nM,625.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,0.625
58393,Median N= 2,20183185,CHEMBL4296188,"Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513149,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3372884,=,40,1,=,MIC,nM,2500.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM,UO_0000065,2.5
58394,Median N= 2; Range 1.25 - 0.625  Um,20183186,CHEMBL4296184,"Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513149,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3372884,=,40,1,=,MIC,nM,625.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.625
58395,Median N= 2; Maxinhib 4.8 Pct,20242252,CHEMBL4296189,"Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513161,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3391446,>,40,1,>,MIC,nM,20000.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,uM,UO_0000065,20.0
58396,Median N= 2; Maxinhib 13.3 Pct,20242253,CHEMBL4296190,"Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570)",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513161,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3391446,>,40,1,>,MIC,nM,20000.0,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,MIC,uM,UO_0000065,20.0
58397,Median N= 2; Range <=0.1563 - <=0.1562  Um,20242254,CHEMBL4296185,"Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513161,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3391446,<=,40,1,<=,MIC,nM,156.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.1562
58398,Median N= 2,20242255,CHEMBL4296186,"Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513161,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3391446,=,40,1,=,MIC,nM,5000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,uM,UO_0000065,5.0
58399,Median N= 2,20242256,CHEMBL4296187,"Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513161,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3391446,=,40,1,=,MIC,nM,2500.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,2.5
58400,Median N= 2,20242257,CHEMBL4296188,"Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513161,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3391446,=,40,1,=,MIC,nM,10000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM,UO_0000065,10.0
58401,Median N= 2; Range <=0.156 - <=0.1563  Um,20242258,CHEMBL4296802,"Antibacterial activity against Pseudomonas aeruginosa PAO397 [PAO1 d(mexAB-oprM) d(mexCD-oprJ) d(mexEF-oprN) d(mexJKL) d(mexXY) d(opmH)] (CO-ADD:GN_211); MIC in CAMBH media using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513161,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3391446,<=,40,1,<=,MIC,nM,156.3,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,0.1563
58402,Median N= 2,20242259,CHEMBL4296184,"Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600)",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4513161,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3391446,=,40,1,=,MIC,nM,2500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,2.5
58403,,20640485,CHEMBL4612952,Induction of Escherichia coli K12 MG1655 recA promotor measured at 30 mins interval for 20 hrs by fluorescence assay relative to control,B,BAO_0000179,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4610120,J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3473707,=,1,0,=,FC,,20.0,CHEMBL3434,Escherichia coli K-12,Recombinase A,83333.0,,FC,,,20.0
58404,,20640492,CHEMBL4612953,Induction of Escherichia coli K12 MG1655 lexA promotor measured at 30 mins interval for 20 hrs by fluorescence assay relative to control,B,BAO_0000179,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4610120,J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3473707,=,1,0,=,FC,,5.0,CHEMBL4630871,Escherichia coli,LexA repressor,562.0,,FC,,,5.0
58405,,20640499,CHEMBL4612954,Induction of Escherichia coli K12 MG1655 recN promotor measured at 30 mins interval for 20 hrs by fluorescence assay relative to control,B,BAO_0000179,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4610120,J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3473707,=,1,0,=,FC,,14.0,CHEMBL4630870,Escherichia coli,DNA repair protein RecN,562.0,,FC,,,14.0
58406,,20640506,CHEMBL4612955,Induction of Escherichia coli K12 MG1655 sulA promotor measured at 30 mins interval for 20 hrs by fluorescence assay relative to control,B,BAO_0000179,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4610120,J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3473707,=,1,0,=,FC,,17.0,CHEMBL1287594,Escherichia coli K-12,Cell division inhibitor sulA,83333.0,,FC,,,17.0
58407,,20644742,CHEMBL4613931,Antimicrobial activity against Mycobacterium leprae assessed as microbial growth at 0.375 ug/ml in presence of 0.1 ug/ml rifampin measured at 4 weeks (Rvb = 147 +/- 19.1%),F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3474761,=,1,0,=,Activity,%,87.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,Activity,%,UO_0000187,87.0
58408,,20644743,CHEMBL4613932,Antimicrobial activity against Mycobacterium leprae assessed as microbial growth at 0.375 ug/ml in presence of 0.2 ug/ml rifampin measured at 4 weeks (Rvb = 147 +/- 19.1%),F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3474761,=,1,0,=,Activity,%,0.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,Activity,%,UO_0000187,0.0
58409,,20644744,CHEMBL4613933,Antimicrobial activity against Mycobacterium leprae assessed as microbial growth at 0.1875 ug/ml in presence of 0.025 ug/ml rifabutin measured at 4 weeks (Rvb = 147 +/- 19.1%),F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3474761,=,1,0,=,Activity,%,133.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,Activity,%,UO_0000187,133.0
58410,,20644745,CHEMBL4613934,Antimicrobial activity against Mycobacterium leprae assessed as microbial growth at 0.1875 ug/ml in presence of 0.05 ug/ml rifabutin measured at 4 weeks (Rvb = 147 +/- 19.1%),F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3474761,=,1,0,=,Activity,%,0.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,Activity,%,UO_0000187,0.0
58411,,20644746,CHEMBL4613935,Antimicrobial activity against Mycobacterium leprae assessed as microbial growth at 0.1875 ug/ml in presence of 0.0062 ug/ml KRM-1648 measured at 4 weeks (Rvb = 147 +/- 19.1%),F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3474761,=,1,0,=,Activity,%,115.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,Activity,%,UO_0000187,115.0
58412,,20644747,CHEMBL4613936,Antimicrobial activity against Mycobacterium leprae assessed as microbial growth at 0.1875 ug/ml in presence of 0.0125 ug/ml KRM-1648 measured at 4 weeks (Rvb = 147 +/- 19.1%),F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3474761,=,1,0,=,Activity,%,0.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,Activity,%,UO_0000187,0.0
58413,,20644760,CHEMBL4613949,Antimicrobial activity against Mycobacterium leprae assessed as fractional inhibitory concentration index at 0.375 ug/ml in presence of 0.2 ug/ml rifampin measured at 4 weeks,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3474761,=,1,0,=,FICI,,1.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,FICI,,,1.0
58414,,20644761,CHEMBL4613950,Antimicrobial activity against Mycobacterium leprae assessed as fractional inhibitory concentration index at 0.1875 ug/ml in presence of 0.05 ug/ml rifabutin measured at 4 weeks,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3474761,=,1,0,=,FICI,,0.5,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,FICI,,,0.5
58415,,20644762,CHEMBL4613951,Antimicrobial activity against Mycobacterium leprae assessed as fractional inhibitory concentration index at 0.1875 ug/ml in presence of 0.0125 ug/ml KRM-1648 measured at 4 weeks,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4613212,Bioorg Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3474761,=,1,0,=,FICI,,0.5,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,FICI,,,0.5
58416,,20705851,CHEMBL4628193,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4627293,Bioorg Med Chem Lett,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3487193,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
58417,,20705852,CHEMBL4628194,Antimicrobial activity against methicillin- resistant Staphylococcus aureus ATCC 33591,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4627293,Bioorg Med Chem Lett,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3487193,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
58418,,20705853,CHEMBL4628195,Antimicrobial activity against Vancomycin-sensitive Enterococcus faecalis ATCC 29212,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4627293,Bioorg Med Chem Lett,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3487193,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
58419,,20705854,CHEMBL4628196,Antimicrobial activity against Vancomycin-resistant Enterococcus faecalis ATCC 51299,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4627293,Bioorg Med Chem Lett,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3487193,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
58420,,20705855,CHEMBL4628197,Antimicrobial activity against Escherichia coli ATCC 25922,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4627293,Bioorg Med Chem Lett,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3487193,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
58421,,20705856,CHEMBL4628198,Antimicrobial activity against ESBL-producing Klebsiella pneumoniae ATCC 700603,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4627293,Bioorg Med Chem Lett,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3487193,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
58422,,20705857,CHEMBL4628199,Antimicrobial activity against NDM-1 producing Klebsiella pneumoniae ATCC BAA-2146,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4627293,Bioorg Med Chem Lett,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3487193,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,128.0
58423,,20705858,CHEMBL4628200,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4627293,Bioorg Med Chem Lett,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3487193,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
58424,,20705859,CHEMBL4628201,Antimicrobial activity against Enterobacter aerogenes ATCC 45102,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4627293,Bioorg Med Chem Lett,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3487193,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.25
58425,,20705860,CHEMBL4628202,Antimicrobial activity against Citrobacter freundii ATCC 43864,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4627293,Bioorg Med Chem Lett,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3487193,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,0.03
58426,,20705861,CHEMBL4628203,Antimicrobial activity against Providencia rettgeri ATCC 31052,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4627293,Bioorg Med Chem Lett,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3487193,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,MIC,ug ml-1,UO_0000274,0.125
58427,,20705862,CHEMBL4628204,Antimicrobial activity against Proteus vulgaris ATCC 29905,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4627293,Bioorg Med Chem Lett,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3487193,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.125
58428,,20705863,CHEMBL4628205,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis ATCC 12228,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4627293,Bioorg Med Chem Lett,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3487193,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
58429,,20705864,CHEMBL4628206,Antimicrobial activity against vancomycin-resistant Enterococcus faecium ATCC 700221,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4627293,Bioorg Med Chem Lett,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3487193,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,32.0
58430,,20705865,CHEMBL4628207,Antimicrobial activity against Klebsiella pneumoniae 7,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4627293,Bioorg Med Chem Lett,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3487193,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
58431,,20705866,CHEMBL4628208,Antimicrobial activity against Acinetobacter calcoaceticus ATCC 19606,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4627293,Bioorg Med Chem Lett,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3487193,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC,ug ml-1,UO_0000274,0.25
58432,,20708666,CHEMBL4628717,Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis G122 incubated for 5 days by alamar blue based colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4627328,Bioorg Med Chem Lett,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3487838,=,1,1,=,MIC,nM,540.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.54
58433,,20708691,CHEMBL4628716,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 5 days by alamar blue based colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4627328,Bioorg Med Chem Lett,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3487838,=,1,1,=,MIC,nM,540.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.54
58434,,22071308,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4495565,,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3359818,=,52,1,=,Inhibition,%,0.12,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,0.12
58435,,22075873,CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4495565,,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3364383,=,52,1,=,Inhibition,%,-0.06,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,inhibition,%,UO_0000187,-0.06
58436,,22420050,CHEMBL4673410,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 using cyrene as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3513099,=,1,1,=,MIC80,nM,780.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC80,uM,UO_0000065,0.78
58437,,22420058,CHEMBL4673411,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 using DMSO as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3513099,=,1,1,=,MIC80,nM,780.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC80,uM,UO_0000065,0.78
58438,,22420066,CHEMBL4673412,Antibacterial activity against Acinetobacter baumannii ATCC 19606 using cyrene as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3513099,=,1,1,=,MIC80,nM,390.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC80,uM,UO_0000065,0.39
58439,,22420074,CHEMBL4673413,Antibacterial activity against Acinetobacter baumannii ATCC 19606 using DMSO as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3513099,=,1,1,=,MIC80,nM,390.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC80,uM,UO_0000065,0.39
58440,,22420082,CHEMBL4673414,Antibacterial activity against Pseudomonas aeruginosa ATCC 27893 using cyrene as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3513099,=,1,1,=,MIC80,nM,1600.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC80,uM,UO_0000065,1.6
58441,,22420090,CHEMBL4673415,Antibacterial activity against Pseudomonas aeruginosa ATCC 27893 using DMSO as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3513099,=,1,1,=,MIC80,nM,1600.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC80,uM,UO_0000065,1.6
58442,,22420098,CHEMBL4673416,Antibacterial activity against Escherichia coli ATCC 25922 using cyrene as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3513099,=,1,1,=,MIC80,nM,19.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC80,uM,UO_0000065,0.019
58443,,22420106,CHEMBL4673417,Antibacterial activity against Escherichia coli ATCC 25922 using DMSO as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3513099,=,1,1,=,MIC80,nM,19.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC80,uM,UO_0000065,0.019
58444,,22420114,CHEMBL4673418,Antibacterial activity against Enterococcus faecalis ATCC 51299 using DMSO as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3513099,=,1,1,=,MIC80,nM,190.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC80,uM,UO_0000065,0.19
58445,,22420122,CHEMBL4673419,Antibacterial activity against Staphylococcus aureus ATCC 43300 using Cyrene as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3513099,=,1,1,=,MIC80,nM,780.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC80,uM,UO_0000065,0.78
58446,,22420130,CHEMBL4673420,Antibacterial activity against Staphylococcus aureus ATCC 43300 using DMSO as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3513099,=,1,1,=,MIC80,nM,780.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC80,uM,UO_0000065,0.78
58447,,22420154,CHEMBL4673431,Antibacterial activity against Enterococcus faecalis ATCC 51299 using Cyrene as solvent by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4673173,RSC Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3513099,=,1,1,=,MIC80,nM,390.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC80,uM,UO_0000065,0.39
58448,,22448389,CHEMBL4680380,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of visible growth incubated for 18 hrs by CLSI protocol based microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680060,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3518415,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
58449,,22448402,CHEMBL4680381,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 assessed as inhibition of visible growth incubated for 18 hrs by CLSI protocol based microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680060,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3518415,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
58450,,22448415,CHEMBL4680382,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis clinical isolate CANWARD-2008 81388 assessed as inhibition of visible growth incubated for 18 hrs by CLSI protocol based microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680060,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3518415,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
58451,,22448428,CHEMBL4680383,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate CAN-ICU 61589 assessed as inhibition of visible growth incubated for 18 hrs by CLSI protocol based microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680060,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3518415,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
58452,,22448441,CHEMBL4680384,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 assessed as inhibition of visible growth incubated for 18 hrs by CLSI protocol based microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680060,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3518415,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
58453,,22448454,CHEMBL4680385,Antibacterial activity against Enterococcus faecalis ATCC 29212 assessed as inhibition of visible growth incubated for 18 hrs by CLSI protocol based microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680060,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3518415,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
58454,,22448467,CHEMBL4680386,Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of visible growth incubated for 18 hrs by CLSI protocol based microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680060,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3518415,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
58455,,22448480,CHEMBL4680387,Antibacterial activity against Enterobacter cloacae 117029 assessed as inhibition of visible growth incubated for 18 hrs by CLSI protocol based microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680060,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3518415,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.125
58456,,22448493,CHEMBL4680388,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of visible growth incubated for 18 hrs by CLSI protocol based microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680060,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3518415,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
58457,,22448506,CHEMBL4680389,Antibacterial activity against Stenotrophomonas maltophilia clinical isolate CAN-ICU 62584 assessed as inhibition of visible growth incubated for 18 hrs by CLSI protocol based microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680060,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3518415,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,4.0
58458,,22448519,CHEMBL4680390,Antibacterial activity against Acinetobacter baumannii clinical isolate CAN-ICU 63169 assessed as inhibition of visible growth incubated for 18 hrs by CLSI protocol based microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680060,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3518415,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,1.0
58459,,22448532,CHEMBL4680391,Antibacterial activity against Klebsiella pneumoniae 116381 assessed as inhibition of visible growth incubated for 18 hrs by CLSI protocol based microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680060,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3518415,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,128.0
58460,,22448570,CHEMBL4680395,Potentiation of conjugate 10-induced antibacterial activity against wild type Pseudomonas aeruginosa PAO1 assessed as conjugate 10 MIC measured after 18 hrs by CLSI protocol based microbroth dilution method (Rvb = 64 to 128 ug/ml),F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680060,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3518415,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
58461,,22448573,CHEMBL4680396,Potentiation of conjugate 11-induced antibacterial activity against wild type Pseudomonas aeruginosa PAO1 assessed as conjugate 11 MIC measured after 18 hrs by CLSI protocol based microbroth dilution method (Rvb = 64 to 128 ug/ml),F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680060,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3518415,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
58462,,22448576,CHEMBL4680397,Potentiation of conjugate 12-induced antibacterial activity against wild type Pseudomonas aeruginosa PAO1 assessed as conjugate 12 MIC measured after 18 hrs by CLSI protocol based microbroth dilution method (Rvb = 64 to 128 ug/ml),F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680060,Medchemcomm,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3518415,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
58463,,22476820,CHEMBL4686416,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis ATCC 12228 assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522810,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.12
58464,,22476823,CHEMBL4686417,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 16-5 assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522810,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,8.0
58465,,22476826,CHEMBL4686418,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522810,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
58466,,22476829,CHEMBL4686419,Antibacterial activity against methicillin-resisitant Staphylococcus aureus 16-30 assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522810,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58467,,22476832,CHEMBL4686420,Antibacterial activity against ESBL negative Escherichia coli 16-7 assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522810,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
58468,,22476835,CHEMBL4686421,Antibacterial activity against ESBL positive Escherichia coli 16-1 assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522810,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
58469,,22476838,CHEMBL4686422,Antibacterial activity against NDM-1 producing Escherichia coli ATCC 2469 assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522810,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
58470,,22476841,CHEMBL4686423,Antibacterial activity against NDM-1 producing Klebsiella pneumoniae ATCC BAA-2146 assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522810,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,128.0
58471,,22476844,CHEMBL4686424,Antibacterial activity against ESBL producing Klebsiella pneumoniae 16-14 assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522810,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.5
58472,,22476847,CHEMBL4686425,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis ATCC 29212 assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522810,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
58473,,22476850,CHEMBL4686426,Antibacterial activity against vancomycin-resistant Enterococcus faecium ATCC 700221 assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522810,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,32.0
58474,,22476853,CHEMBL4686427,Antibacterial activity against Acinetobacter baumannii ATCC 19606 assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522810,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.25
58475,,22476856,CHEMBL4686428,Antibacterial activity against Enterobacter cloacae ATCC 43560 assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522810,<,1,1,<,MIC,ug.mL-1,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.03
58476,,22476859,CHEMBL4686429,Antibacterial activity against Enterobacter aerogenes ATCC 13048 assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522810,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.06
58477,,22476862,CHEMBL4686430,Antibacterial activity against Shigella ATCC 12022 assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522810,<,1,1,<,MIC,ug.mL-1,0.03,CHEMBL614594,Shigella,Shigella,620.0,,MIC,ug ml-1,UO_0000274,0.03
58478,,22476865,CHEMBL4686431,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as reduction in microbial growth,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4680236,Eur J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3522810,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
58479,,22755664,CHEMBL4700694,Antibacterial activity against Escherichia coli ATCC 25922 after overnight incubation by CLSI M7-A9 based method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
58480,,22755674,CHEMBL4700695,Antibacterial activity against Enterococcus faecalis ATCC 29212 after overnight incubation by CLSI M7-A9 based method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.03
58481,,22755999,CHEMBL4700726,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 13-3,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.03
58482,,22756002,CHEMBL4700727,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.03
58483,,22756005,CHEMBL4700728,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis ATCC 12228,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.03
58484,,22756008,CHEMBL4700729,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.03
58485,,22756011,CHEMBL4700730,Antibacterial activity against Enterococcus faecalis ATCC 51299,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.03
58486,,22756014,CHEMBL4700731,Antibacterial activity against Enterococcus faecium ATCC 700221,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.03
58487,,22756017,CHEMBL4700732,Antibacterial activity against Enterococcus faecium 13-7,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.03
58488,,22756020,CHEMBL4700733,Antibacterial activity against Escherichia coli 14-11,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
58489,,22756023,CHEMBL4700734,Antibacterial activity against Klebsiella pneumoniae ATCC 700603,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
58490,,22756026,CHEMBL4700735,Antibacterial activity against Klebsiella pneumoniae 7,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
58491,,22756029,CHEMBL4700736,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.03
58492,,22756032,CHEMBL4700737,Antibacterial activity against Acinetobacter calcoaceticus ATCC 19606,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC,ug ml-1,UO_0000274,0.03
58493,,22756035,CHEMBL4700738,Antibacterial activity against Enterobacter cloacae ATCC 43560,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.03
58494,,22756038,CHEMBL4700739,Antibacterial activity against Enterobacter aerogenes ATCC 13048,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.03
58495,,22756041,CHEMBL4700740,Antibacterial activity against Serratia marcescens ATCC 21074,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.03
58496,,22756044,CHEMBL4700741,Antibacterial activity against Morganella morganii ATCC 25830,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC,ug ml-1,UO_0000274,0.03
58497,,22756047,CHEMBL4700742,Antibacterial activity against Providencia rettgeri ATCC 31052,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,MIC,ug ml-1,UO_0000274,0.03
58498,,22756050,CHEMBL4700743,Antibacterial activity against Proteus vulgaris ATCC 29905,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.03
58499,,22756053,CHEMBL4700744,Antibacterial activity against Proteus mirabilis 13-1,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,0.03
58500,,22756056,CHEMBL4700745,Antibacterial activity against Stenotrophomonas maltophilia ATCC 13636,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,0.03
58501,,22756059,CHEMBL4700746,Antibacterial activity against Citrobacter freundii ATCC 43864,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699440,Eur J Med Chem,2019.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532132,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,0.03
58502,,22767541,CHEMBL4703499,Antibacterial activity against Methicillin-resistant Staphylococcus aureus by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534544,>=,1,1,>=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
58503,,22767548,CHEMBL4703499,Antibacterial activity against Methicillin-resistant Staphylococcus aureus by CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534544,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,16.0
58504,,22767555,CHEMBL4703499,Antibacterial activity against Methicillin-resistant Staphylococcus aureus by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534544,>,1,1,>,MIC90,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,128.0
58505,,22767917,CHEMBL4703526,Antibacterial activity against Vancomycin-resistant Enterococcus by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534544,>=,1,1,>=,MIC,ug.mL-1,0.5,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC,ug ml-1,UO_0000274,0.5
58506,,22767923,CHEMBL4703526,Antibacterial activity against Vancomycin-resistant Enterococcus by CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534544,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC50,ug ml-1,UO_0000274,8.0
58507,,22767929,CHEMBL4703526,Antibacterial activity against Vancomycin-resistant Enterococcus by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534544,=,1,1,=,MIC90,ug.mL-1,128.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC90,ug ml-1,UO_0000274,128.0
58508,,22767935,CHEMBL4703527,Antibacterial activity against genotype penicillin-resistant Streptococcus pneumoniae by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534544,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
58509,,22767942,CHEMBL4703527,Antibacterial activity against genotype penicillin-resistant Streptococcus pneumoniae by CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534544,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,2.0
58510,,22767949,CHEMBL4703527,Antibacterial activity against genotype penicillin-resistant Streptococcus pneumoniae by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4699558,Bioorg Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3534544,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,2.0
58511,,22803761,CHEMBL4711982,Antibacterial activity against Escherichia coli ATCC 25922 measured after 16 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4706624,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3541247,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
58512,,22803777,CHEMBL4711983,Antibacterial activity against Staphylococcus aureus ATCC 29213 measured after 16 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4706624,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3541247,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.015
58513,,22803794,CHEMBL4711984,Antibacterial activity against Klebsiella pneumoniae BAA-1705 measured after 16 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4706624,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3541247,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
58514,,22803810,CHEMBL4711985,Antibacterial activity against Acinetobacter baumannii BAA1605 measured after 16 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4706624,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3541247,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
58515,,22803826,CHEMBL4711986,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 measured after 16 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4706624,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3541247,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
58516,Not Determined,22803842,CHEMBL4711987,Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 measured after 7 days by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4706624,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3541247,,1,0,,MIC,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,,,
58517,,22803864,CHEMBL4711988,Antimycobacterial activity against Mycobacterium abscessus ATCC 19977 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4706624,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3541247,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,MIC,ug ml-1,UO_0000274,1.0
58518,,22803884,CHEMBL4711989,Antimycobacterial activity against Mycobacterium fortuitum ATCC 6841 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4706624,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3541247,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,MIC,ug ml-1,UO_0000274,0.03
58519,,22803904,CHEMBL4711990,Antimycobacterial activity against Mycobacterium chelonae ATCC 35752 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4706624,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3541247,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,MIC,ug ml-1,UO_0000274,0.03
58520,,22803931,CHEMBL4711993,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 measured after 16 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4706624,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3541247,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58521,,22803940,CHEMBL4711994,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR100 measured after 16 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4706624,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3541247,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
58522,,22803949,CHEMBL4711995,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR119 measured after 16 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4706624,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3541247,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
58523,,22803958,CHEMBL4711996,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR10129 measured after 16 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4706624,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3541247,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
58524,,22803967,CHEMBL4711997,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR10198 measured after 16 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4706624,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3541247,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
58525,,22803976,CHEMBL4711998,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR10192 measured after 16 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4706624,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3541247,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
58526,,22803985,CHEMBL4711999,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR10186 measured after 16 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4706624,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3541247,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
58527,,22803994,CHEMBL4712000,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR10193 measured after 16 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4706624,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3541247,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58528,,22804003,CHEMBL4712001,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR10194 measured after 16 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4706624,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3541247,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58529,,22804012,CHEMBL4712002,Antibacterial activity against methicillin-resistant Staphylococcus aureus NR10191 measured after 16 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4706624,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3541247,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58530,,22804021,CHEMBL4712003,Antibacterial activity against vancomycin-resistant Staphylococcus aureus VRS1 measured after 16 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4706624,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3541247,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58531,,22804030,CHEMBL4712004,Antibacterial activity against vancomycin-resistant Staphylococcus aureus VRS4 measured after 16 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4706624,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3541247,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
58532,,22804039,CHEMBL4712005,Antibacterial activity against vancomycin-resistant Staphylococcus aureus VRS12 measured after 16 to 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4706624,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3541247,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58533,,22915064,CHEMBL4735153,Antibacterial activity against multidrug-resistant Escherichia coli BW25113 harboring AcrB deletion mutant by two-fold broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4732114,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3557783,=,1,1,=,MIC,ug.mL-1,0.04,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.04
58534,,23187431,CHEMBL4817940,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis ATCC 12228 by agar method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4814028,Bioorg Med Chem Lett,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605618,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.12
58535,,23187468,CHEMBL4817941,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 16-5 by agar method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4814028,Bioorg Med Chem Lett,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605618,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,8.0
58536,,23187505,CHEMBL4817942,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 by agar method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4814028,Bioorg Med Chem Lett,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605618,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
58537,,23187542,CHEMBL4817943,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 by agar method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4814028,Bioorg Med Chem Lett,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605618,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
58538,,23187579,CHEMBL4817944,Antibacterial activity against Vancomycin-sensitive Enterococcus faecalis ATCC 29212 by agar method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4814028,Bioorg Med Chem Lett,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605618,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
58539,,23187616,CHEMBL4817945,Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51299 by agar method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4814028,Bioorg Med Chem Lett,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605618,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
58540,,23187653,CHEMBL4817946,Antibacterial activity against ESBLs positive Escherichia coli ATCC 35218 by agar method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4814028,Bioorg Med Chem Lett,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605618,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
58541,,23187690,CHEMBL4817947,Antibacterial activity against ESBLs negative Escherichia coli ATCC 25922 by agar method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4814028,Bioorg Med Chem Lett,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605618,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
58542,,23187727,CHEMBL4817948,Antibacterial activity against NDM-1 positive Escherichia coli ATCC 2469 by agar method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4814028,Bioorg Med Chem Lett,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605618,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
58543,,23187764,CHEMBL4817949,Antibacterial activity against carbapenem-resistant Acinetobacter baumannii 16-33 by agar method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4814028,Bioorg Med Chem Lett,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605618,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,2.0
58544,,23259740,CHEMBL4832875,Antibacterial activity against Staphylococcus aureus ATCC29213 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4831516,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618573,=,1,0,=,MIC100,ug ml-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC100,ug ml-1,UO_0000274,0.5
58545,,23259773,CHEMBL4832876,Antibacterial activity against Enterococcus faecalis ATCC29212 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4831516,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618573,=,1,0,=,MIC100,ug ml-1,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC100,ug ml-1,UO_0000274,0.25
58546,,23259806,CHEMBL4832877,Antibacterial activity against Bacillus subtilis assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4831516,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618573,=,1,0,=,MIC100,ug ml-1,0.5,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC100,ug ml-1,UO_0000274,0.5
58547,,23259839,CHEMBL4832878,Antibacterial activity against Micrococcus luteus assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4831516,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618573,=,1,0,=,MIC100,ug ml-1,0.25,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC100,ug ml-1,UO_0000274,0.25
58548,,23259872,CHEMBL4832879,Antibacterial activity against Escherichia coli ATCC25922 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4831516,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618573,=,1,0,=,MIC100,ug ml-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC100,ug ml-1,UO_0000274,0.5
58549,,23259905,CHEMBL4832880,Antibacterial activity against Stenotrophomonas maltophilia assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4831516,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618573,=,1,0,=,MIC100,ug ml-1,0.5,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC100,ug ml-1,UO_0000274,0.5
58550,,23259938,CHEMBL4832881,Antibacterial activity against Salmonella enterica 349812 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4831516,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618573,=,1,0,=,MIC100,ug ml-1,0.25,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,MIC100,ug ml-1,UO_0000274,0.25
58551,,23259971,CHEMBL4832882,Antibacterial activity against Salmonella enterica 8389 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4831516,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618573,=,1,0,=,MIC100,ug ml-1,0.25,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,MIC100,ug ml-1,UO_0000274,0.25
58552,Not Determined,23260037,CHEMBL4832884,"Selectivity index, HC50 for hemolytic activity in sheep RBC to MIC for antibacterial activity against Staphylococcus aureus ATCC29213",T,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4831516,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3618573,,1,0,,Selectivity Index,,,CHEMBL612558,,ADMET,,,Selectivity Index,,,
58553,,23260068,CHEMBL4832885,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate M-11 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4831516,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618573,=,1,0,=,MIC100,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC100,ug ml-1,UO_0000274,1.0
58554,,23260099,CHEMBL4832886,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate M-12 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4831516,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618573,=,1,0,=,MIC100,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC100,ug ml-1,UO_0000274,1.0
58555,,23260130,CHEMBL4832887,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate M-13 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4831516,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618573,=,1,0,=,MIC100,ug ml-1,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC100,ug ml-1,UO_0000274,5.0
58556,,23260161,CHEMBL4832888,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate M-14 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4831516,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618573,=,1,0,=,MIC100,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC100,ug ml-1,UO_0000274,1.0
58557,,23260192,CHEMBL4832889,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate M-15 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4831516,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618573,=,1,0,=,MIC100,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC100,ug ml-1,UO_0000274,1.0
58558,,23260223,CHEMBL4832890,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate M-16 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4831516,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618573,=,1,0,=,MIC100,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC100,ug ml-1,UO_0000274,1.0
58559,,23260254,CHEMBL4832891,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate M-17 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4831516,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618573,=,1,0,=,MIC100,ug ml-1,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC100,ug ml-1,UO_0000274,5.0
58560,,23260285,CHEMBL4832892,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate M-18 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4831516,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618573,=,1,0,=,MIC100,ug ml-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC100,ug ml-1,UO_0000274,0.5
58561,,23260316,CHEMBL4832893,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate M-19 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4831516,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618573,=,1,0,=,MIC100,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC100,ug ml-1,UO_0000274,1.0
58562,,23260347,CHEMBL4832894,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate M-20 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4831516,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3618573,=,1,0,=,MIC100,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC100,ug ml-1,UO_0000274,1.0
58563,,23292517,CHEMBL4839890,Antibacterial activity against wild type Pseudomonas aeruginosa LESB58 assessed as reduction in bacterial growth by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4837258,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624496,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
58564,,23292523,CHEMBL4839891,Antibacterial activity against wild type Pseudomonas aeruginosa LESB58 LpxA Ser150Ala mutant assessed as reduction in bacterial growth by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4837258,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624496,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
58565,,23292529,CHEMBL4839892,Antibacterial activity against wild type Pseudomonas aeruginosa LESB58 LpxA Gly120Ala mutant assessed as reduction in bacterial growth by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4837258,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624496,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
58566,,23292535,CHEMBL4839893,Antibacterial activity against wild type Pseudomonas aeruginosa LESB58 RS21000 and RS21005 mutant assessed as reduction in bacterial growth by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4837258,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624496,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
58567,,23292541,CHEMBL4839894,Antibacterial activity against wild type Pseudomonas aeruginosa LESB58 LpxA Ser150Ala mutant assessed as resistance development by measuring fold increase in MIC,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4837258,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3624496,=,1,0,=,FC,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,0.5
58568,,23292547,CHEMBL4839895,Antibacterial activity against wild type Pseudomonas aeruginosa LESB58 LpxA Gly120Ala mutant assessed as resistance development by measuring fold increase in MIC,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4837258,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3624496,=,1,0,=,FC,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,1.0
58569,,23292553,CHEMBL4839896,Antibacterial activity against wild type Pseudomonas aeruginosa LESB58 RS21000 and RS21005 mutant assessed as resistance development by measuring fold increase in MIC,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4837258,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3624496,=,1,0,=,FC,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,1.0
58570,,23293869,CHEMBL4840040,Antibacterial activity against Streptococcus pyogenes isolates by CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4837261,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624586,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC50,ug ml-1,UO_0000274,8.0
58571,,23293870,CHEMBL4840040,Antibacterial activity against Streptococcus pyogenes isolates by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4837261,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624586,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,ug ml-1,UO_0000274,64.0
58572,,23293872,CHEMBL4840041,Antibacterial activity against Klebsiella pneumoniae isolates by CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4837261,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624586,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,0.03
58573,,23293873,CHEMBL4840041,Antibacterial activity against Klebsiella pneumoniae isolates by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4837261,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624586,=,1,1,=,MIC90,ug.mL-1,0.015,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,0.015
58574,,23293875,CHEMBL4840042,Antibacterial activity against Enterobacter cloacae isolates by CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4837261,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624586,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC50,ug ml-1,UO_0000274,0.12
58575,,23293876,CHEMBL4840042,Antibacterial activity against Enterobacter cloacae isolates by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4837261,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624586,=,1,1,=,MIC90,ug.mL-1,0.015,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC90,ug ml-1,UO_0000274,0.015
58576,,23293878,CHEMBL4840043,Antibacterial activity against Escherichia coli isolates by CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4837261,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624586,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,0.03
58577,,23293879,CHEMBL4840043,Antibacterial activity against Escherichia coli isolates by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4837261,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624586,=,1,1,=,MIC90,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,0.015
58578,,23293881,CHEMBL4840044,Antibacterial activity against Pseudomonas aeruginosa isolates by CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4837261,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624586,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC50,ug ml-1,UO_0000274,1.0
58579,,23293882,CHEMBL4840044,Antibacterial activity against Pseudomonas aeruginosa isolates by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4837261,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3624586,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,0.5
58580,,23297968,CHEMBL4841392,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as bacterial growth inhibition incubated for 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3625514,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
58581,,23297973,CHEMBL4841393,Antibacterial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition incubated for 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3625514,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
58582,,23297980,CHEMBL4841394,Antibacterial activity against Acinetobacter baumannii BAA 1605 assessed as bacterial growth inhibition incubated for 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3625514,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
58583,,23297987,CHEMBL4841395,Antibacterial activity against Klebsiella pneumoniae BAA-1705 assessed as bacterial growth inhibition incubated for 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3625514,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
58584,,23297992,CHEMBL4841396,Antibacterial activity against Enterococcus NR 31884 assessed as bacterial growth inhibition incubated for 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3625514,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC,ug ml-1,UO_0000274,0.25
58585,,23297997,CHEMBL4841397,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition incubated for 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3625514,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58586,,23298008,CHEMBL4841399,"Antibacterial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition in presence of outermembrane permeabilizer, PMBN incubated for 16 to 18 hrs by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3625514,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
58587,,23298012,CHEMBL4841400,"Antibacterial activity against Acinetobacter baumannii BAA-1605 ssessed as bacterial growth inhibition in presence of outermembrane permeabilizer, PMBN incubated for 16 to 18 hrs by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3625514,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
58588,,23298068,CHEMBL4841449,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as time for increase by 1 log10CFU at 1XMIC incubated for 1 hr followed by drug wash-out and measured every single 1 hr,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,3625514,=,1,1,=,TIME,hr,2.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,2.5
58589,,23298071,CHEMBL4841450,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as time for increase by 1 log10CFU at 10XMIC incubated for 1 hr followed by drug wash-out and measured every single 1 hr,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,3625514,=,1,1,=,TIME,hr,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,3.0
58590,,23298074,CHEMBL4841451,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as time for post-antibiotic effect at 1XMIC incubated for 1 hr followed by drug wash-out and measured every single 1 hr,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,3625514,=,1,1,=,TIME,hr,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,0.5
58591,,23298077,CHEMBL4841452,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as time for post-antibiotic effect at 10XMIC incubated for 1 hr followed by drug wash-out and measured every single 1 hr,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,3625514,=,1,1,=,TIME,hr,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,1.0
58592,Not Active,23298079,CHEMBL4841453,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial growth at sub-MIC incubated for 25 days,F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL4840338,J Nat Prod,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3625514,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
58593,,24350931,CHEMBL5032142,"Antibacterial activity against Pseudomonas aeruginosa infected in Balb/c mouse stomach assessed as animal survival at 100 mg/kg, ip after 7 days",F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5030557,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3772646,=,1,0,=,Survival,%,100.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Survival,%,UO_0000187,100.0
58594,,24389187,CHEMBL5040846,Antibacterial activity against Escherichia coli ATCC25922 assessed as reduction in microbial growth after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5038623,Eur J Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3778749,=,1,1,=,MIC,ug.mL-1,2.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.5
58595,,24389205,CHEMBL5040847,Antibacterial activity against Staphylococcus aureus ATCC 6538 assessed as reduction in microbial growth after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5038623,Eur J Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3778749,=,1,1,=,MIC,ug.mL-1,1.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.25
58596,,24389223,CHEMBL5040848,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 assessed as reduction in microbial growth after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5038623,Eur J Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3778749,<,1,1,<,MIC,ug.mL-1,0.63,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.63
58597,,24389241,CHEMBL5040849,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as zone of inhibition incubated for 12 hrs by by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5038623,Eur J Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,3778749,=,1,1,=,IZ,mm,1.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,1.25
58598,,24390647,CHEMBL5041089,Inhibition of biofilm formation in methicillin-resistant Staphylococcus aureus assessed as decrease in biofilm mass at 10 uM upon exposure to UV light irradiation and measured after 48 hrs by dilution plate coating method,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5038629,J Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3778897,=,1,1,=,Inhibition,%,19.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,INH,%,UO_0000187,19.0
58599,,24390649,CHEMBL5041091,Inhibition of biofilm formation in methicillin-resistant Staphylococcus aureus assessed as biofilm dispersal effect at 10 uM incubated for 5 hrs followed by exposure to UV light irradiation for 1 min by crystal violet staining based analysis,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5038629,J Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3778897,=,1,0,=,Activity,%,15.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,15.0
58600,,24664272,CHEMBL5097919,Antibacterial activity against methicillin-resistant Staphylococcus aureus strains 15 1 to 4 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5096186,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3843308,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
58601,,24664310,CHEMBL5097920,Antibacterial activity against methicillin-sensitive Staphylococcus aureus strains 15 1 to 4 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5096186,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3843308,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
58602,,24664348,CHEMBL5097921,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis strains 15 1 to 4 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5096186,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3843308,>,1,1,>,MIC,ug.mL-1,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,4.0
58603,,24664386,CHEMBL5097922,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis strains 15 1 to 4 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5096186,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3843308,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
58604,,24664424,CHEMBL5097923,Antibacterial activity against ESBL-producing Escherichia coli ATCC 35218 strains 15 1 to 3 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5096186,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3843308,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
58605,,24664462,CHEMBL5097924,Antibacterial activity against Escherichia coli ATCC 35218 strains 15 1 to 3 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5096186,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3843308,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
58606,,24664500,CHEMBL5097925,Antibacterial activity against multidrug resistant Pseudomonas aeruginosa strains 15 1 to 3 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5096186,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3843308,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
58607,,24664567,CHEMBL5097929,Antibacterial activity against ESBL-producing multidrug resistant Escherichia coli assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5096186,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3843308,=,1,1,=,MIC,nM,8000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,8.0
58608,,24664586,CHEMBL5097930,Antibacterial activity against multidrug resistant wild type Escherichia coli ATCC BAA-2340 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5096186,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3843308,=,1,1,=,MIC,nM,4000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,4.0
58609,,24664605,CHEMBL5097931,Antibacterial activity against multidrug resistant wild type Escherichia coli NCTC 13353 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5096186,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3843308,=,1,1,=,MIC,nM,32000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,32.0
58610,,24664624,CHEMBL5097932,Antibacterial activity against KPC2-producing multidrug resistant Klebsiella pneumoniae assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5096186,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3843308,>=,1,1,>=,MIC,nM,32000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,uM,UO_0000065,32.0
58611,,24664643,CHEMBL5097933,Antibacterial activity agains wild type Klebsiella pneumoniae ATCC BAA-1705 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5096186,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3843308,=,1,1,=,MIC,nM,64000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,uM,UO_0000065,64.0
58612,,24664662,CHEMBL5097934,Antibacterial activity agains wild type Klebsiella pneumoniae ATCC BAA-2470 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5096186,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3843308,=,1,1,=,MIC,nM,16000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,uM,UO_0000065,16.0
58613,,24664681,CHEMBL5097935,Antibacterial activity agains OXA23-producing multidrug resistant Acinetobacter baumannii assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5096186,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3843308,=,1,1,=,MIC,nM,4000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM,UO_0000065,4.0
58614,,24664700,CHEMBL5097936,Antibacterial activity against wild type Acinetobacter baumannii NCTC 13304 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5096186,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3843308,=,1,1,=,MIC,nM,4000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM,UO_0000065,4.0
58615,,24664719,CHEMBL5097937,Antibacterial activity against IMP4-producing multidrug resistant Pseudomonas aeruginosa assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5096186,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3843308,=,1,1,=,MIC,nM,4000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,4.0
58616,,24664738,CHEMBL5097938,Antibacterial activity against wild type Pseudomonas aeruginosa ATCC 27853 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by CLSI based microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5096186,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3843308,=,1,1,=,MIC,nM,2000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,2.0
58617,,24755727,CHEMBL5122557,Antibacterial activity against multidrug resistant Helicobacter pylori G27 assessed as bacterial growth inhibition incubated for 3 days by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5120817,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862365,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,MIC,ug ml-1,UO_0000274,0.25
58618,,24755748,CHEMBL5122558,Antibacterial activity against multidrug resistant Helicobacter pylori HP159 assessed as bacterial growth inhibition incubated for 3 days by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5120817,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862365,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,MIC,ug ml-1,UO_0000274,8.0
58619,,24755769,CHEMBL5122559,Antibacterial activity against multidrug resistant Helicobacter pylori JRES00015 assessed as bacterial growth inhibition incubated for 3 days by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5120817,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862365,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,MIC,ug ml-1,UO_0000274,16.0
58620,,24764754,CHEMBL5124835,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC29213 measured after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5120904,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864115,=,1,1,=,MIC,ug.mL-1,0.078,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.078
58621,,24764765,CHEMBL5124836,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC33591 measured after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5120904,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864115,=,1,1,=,MIC,ug.mL-1,0.078,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.078
58622,,24764776,CHEMBL5124837,Antibacterial activity against methicillin-resistant Staphylococcus aureus R6101 measured after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5120904,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864115,=,1,1,=,MIC,ug.mL-1,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,5.0
58623,,24764787,CHEMBL5124838,Antibacterial activity against Staphylococcus epidermidis ATCC12228 measured after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5120904,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864115,=,1,1,=,MIC,ug.mL-1,0.16,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.16
58624,,24764798,CHEMBL5124839,Antibacterial activity against Bacillus subtilis ATCC6633 measured after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5120904,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864115,<,1,1,<,MIC,ug.mL-1,0.078,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.078
58625,,24764809,CHEMBL5124840,Antibacterial activity against multidrug-resistant Morganella morganii KL-225 measured after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5120904,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864115,=,1,1,=,MIC,ug.mL-1,5.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC,ug ml-1,UO_0000274,5.0
58626,,24764820,CHEMBL5124841,Antibacterial activity against beta-lactamase-producing Morganella morganii ATCC25830 measured after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5120904,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864115,<,1,1,<,MIC,ug.mL-1,0.078,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC,ug ml-1,UO_0000274,0.078
58627,,24833097,CHEMBL5143414,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5137134,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878482,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58628,,24833107,CHEMBL5143415,Antibacterial activity against Enterococcus NR 31903 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5137134,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878482,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC,ug ml-1,UO_0000274,64.0
58629,,24833109,CHEMBL5143416,Antibacterial activity against Klebsiella pneumoniae BAA 1705 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5137134,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878482,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
58630,,24833111,CHEMBL5143417,Antibacterial activity against Acinetobacter baumannii BAA 1605 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5137134,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878482,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
58631,,24833116,CHEMBL5143418,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5137134,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878482,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
58632,,24833118,CHEMBL5143419,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5137134,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878482,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
58633,,24833125,CHEMBL5143422,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in bacterial growth incubated for 16 to 18 hrs in presence of PMBN by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5137134,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878482,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
58634,,24833129,CHEMBL5143423,Antibacterial activity against Acinetobacter baumannii BAA 1605 assessed as reduction in bacterial growth incubated for 16 to 18 hrs in presence of PMBN by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5137134,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878482,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
58635,,24833160,CHEMBL5143450,Antibiofilm activity against Staphylococcus aureus ATCC 29213 assessed as reduction in preformed bacterial biofilm mass at 1 time MIC incubated for 24 hrs by crystal violet staining based microtiter plate reader assay,F,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5137134,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3878482,=,1,0,=,Activity,%,15.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,15.0
58636,,24833163,CHEMBL5143451,Antibacterial activity against Staphylococcus aureus ATCC 29213 infected in mouse J774A.1 cells assessed as reduction in intracellular bacterial cells at 5 times MIC incubated for 24 hrs followed by re-plating on TSA plate and measured after 18 to 24 hrs,F,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5137134,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3878482,=,1,0,=,Activity,log10CFU/ml,0.45,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,log10CFU/ml,,0.45
58637,,24833174,CHEMBL5143461,Synergistic antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial growth incubated for 24 hrs in presence of artocarpin by checkerboard method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5137134,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878482,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
58638,,24833189,CHEMBL5143465,Post antibiotic effect against Staphylococcus aureus ATCC 29213 assessed as time required for 1 log10 increase in CFU at 1 time MIC incubated for 1 hr followed by replacement with drug free medium and measured every 1 hr (Rvb = 2 hrs),F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5137134,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,3878482,=,1,1,=,TIME,hr,2.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,2.5
58639,,24833192,CHEMBL5143466,Post antibiotic effect against Staphylococcus aureus ATCC 29213 assessed as time required for 1 log10 increase in CFU at 10 times MIC incubated for 1 hr followed by replacement with drug free medium and measured every 1 hr (Rvb = 2 hrs),F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5137134,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,3878482,=,1,1,=,TIME,hr,3.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Time,hr,UO_0000032,3.5
58640,,24833195,CHEMBL5143467,Post antibiotic effect against Staphylococcus aureus ATCC 29213 at 1 time MIC incubated for 1 hr followed by replacement with drug free medium and measured every 1 hr (Rvb = 0 hr),F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5137134,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,3878482,=,1,0,=,PAE,hr,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,0.5
58641,,24833198,CHEMBL5143468,Post antibiotic effect against Staphylococcus aureus ATCC 29213 at 10 times MIC incubated for 1 hr followed by replacement with drug free medium and measured every 1 hr (Rvb = 0 hr),F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5137134,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Hour,3878482,=,1,0,=,PAE,hr,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PAE,hr,UO_0000032,1.5
58642,,24833201,CHEMBL5143469,Induction of resistance in Staphylococcus aureus ATCC 29213 assessed as increase in MIC treated over 35 serial passages by resistant development assay,F,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5137134,J Nat Prod,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878482,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL612545,,Unchecked,,,MIC,ug ml-1,UO_0000274,32.0
58643,,24844078,CHEMBL5146140,Antibacterial activity against Mycobacterium Acinetobacter baumannii clinical isolate 43 assessed as bacterial growth inhibition by CLSI protocol based assay,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880666,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC90,ug ml-1,UO_0000274,16.0
58644,,24844081,CHEMBL5146141,Antibacterial activity against Pseudomonas aeruginosa clinical isolate 42 assessed as bacterial growth inhibition by CLSI protocol based assay,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880666,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,32.0
58645,,24844084,CHEMBL5146142,Antibacterial activity against Enterobacter cloacae clinical isolate 41 assessed as bacterial growth inhibition by CLSI protocol based assay,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880666,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC90,ug ml-1,UO_0000274,32.0
58646,,24844087,CHEMBL5146143,Antibacterial activity against Escherichia coli clinical isolate 42 assessed as bacterial growth inhibition by CLSI protocol based assay,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880666,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,16.0
58647,,24844090,CHEMBL5146144,Antibacterial activity against Klebsiella pneumoniae clinical isolate 42 assessed as bacterial growth inhibition by CLSI protocol based assay,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5143607,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880666,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,16.0
58648,,24846048,CHEMBL5146735,Antibacterial activity against methicillin resistant Staphylococcus aureus 032 assessed as inhibition of bacterial growth incubated for 18 hrs by CLSI based serial agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5143624,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881065,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,6.25
58649,,24846063,CHEMBL5146736,"Antibacterial activity against beta-lactams, macrolide and fluoroquinolone resistant Streptococcus pneumoniae 718 assessed as inhibition of bacterial growth incubated for 18 hrs by CLSI based serial agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5143624,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881065,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,12.5
58650,,24846094,CHEMBL5146740,"Antibacterial activity against beta-lactams, macrolide and fluoroquinolone resistant Streptococcus pneumoniae 718 infected in po dosed Swiss mouse septicemia model assessed as protective dose administered on 1 and 5 hrs post infection and measured on day 7",F,BAO_0000188,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5143624,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3881065,>,1,0,>,EC50,mg kg-1,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,EC50,mg kg-1,UO_0000308,100.0
58651,,24852232,CHEMBL5148042,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5143690,Bioorg Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3882412,=,1,1,=,MIC,ug.mL-1,0.0078,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.0078
58652,,24852269,CHEMBL5148043,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5143690,Bioorg Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3882412,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58653,,24852306,CHEMBL5148044,Antibacterial activity against Klebsiella pneumoniae BAA 1705 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5143690,Bioorg Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3882412,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
58654,,24852343,CHEMBL5148045,Antibacterial activity against Acinetobacter baumannii BAA 1605 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5143690,Bioorg Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3882412,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,8.0
58655,,24852380,CHEMBL5148046,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5143690,Bioorg Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3882412,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
58656,,24871663,CHEMBL5153123,Resistance development in methicillin-resistant Staphylococcus aureus 252 assessed as fold increase in resistance after 15 days serial passage upto 256 ug/ml,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5150045,J Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3886721,=,1,0,=,FC,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,64.0
58657,,24890149,CHEMBL5158267,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv measured by MABA assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5154717,Eur J Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3890098,=,1,1,=,MIC,ug.mL-1,0.33,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.33
58658,,24890247,CHEMBL5158272,Antimycobacterial activity against Mycobacterium tuberculosis 13946 clinical isolate measured by MABA assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5154717,Eur J Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3890098,=,1,1,=,MIC,ug.mL-1,1.94,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.94
58659,,24890256,CHEMBL5158273,Antimycobacterial activity against Mycobacterium tuberculosis 14862 clinical isolate measured by MABA assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5154717,Eur J Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3890098,=,1,1,=,MIC,ug.mL-1,1.87,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.87
58660,Active,24905879,CHEMBL5161824,"Invivo antibacterial activity against Staphylococcus aureus ATCC 25923 infected in BALB/c mouse model assessed as reduction of bacterial load in spleen at 100 mg/kg, ip administered as single dose measured after 24 hrs by colony counting based analysis",F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5154803,J Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3892529,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
58661,Active,24905880,CHEMBL5161825,"Invivo antibacterial activity against Staphylococcus aureus ATCC 25923 infected in BALB/c mouse model assessed as reduction of bacterial load in liver at 100 mg/kg, ip administered as single dose measured after 24 hrs by colony counting based analysis",F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5154803,J Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3892529,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
58662,Active,24905881,CHEMBL5161826,"Invivo antibacterial activity against Staphylococcus aureus ATCC 25923 infected in BALB/c mouse model assessed as reduction of bacterial load in kidney at 100 mg/kg, ip administered as single dose measured after 24 hrs by colony counting based analysis",F,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5154803,J Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,,3892529,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
58663,,24909964,CHEMBL5162990,Antibacterial activity against Methicillin resistant Staphylococcus aureus ATCC BAA -1556 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5154823,Eur J Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893127,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
58664,,24909977,CHEMBL5162991,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5154823,Eur J Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893127,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
58665,,24909994,CHEMBL5162993,Antibacterial activity against imipenem resistant Klebsiella pneumoniae ATCC BAA 1705 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5154823,Eur J Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893127,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
58666,,24910007,CHEMBL5162994,Antibacterial activity against Pseudomonas aeruginosa ATCC 27883 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5154823,Eur J Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893127,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
58667,,24976392,CHEMBL5224807,Antibacterial activity against methicillin sensitive Staphylococcus epidermidis ATCC 12228,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,MIC,nM,690.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,0.69
58668,,24976417,CHEMBL5224808,Antibacterial activity against methicillin sensitive Staphylococcus epidermidis 17-13,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,MIC,nM,690.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,0.69
58669,,24976442,CHEMBL5224809,Antibacterial activity against methicillin resistant Staphylococcus epidermidis 19-1,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,MIC,nM,11070.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,11.07
58670,,24976467,CHEMBL5224810,Antibacterial activity against methicillin resistant Staphylococcus epidermidis 19-2,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,MIC,nM,11070.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,11.07
58671,,24976492,CHEMBL5224811,Antibacterial activity against methicillin sensitive Staphylococcus aureus ATCC 29213,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,MIC,nM,690.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.69
58672,,24976517,CHEMBL5224812,Antibacterial activity against methicillin sensitive Staphylococcus aureus 15,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,MIC,nM,690.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.69
58673,,24976542,CHEMBL5224813,Antibacterial activity against methicillin resistant Staphylococcus aureus 20-11,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,MIC,nM,1380.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,1.38
58674,,24976567,CHEMBL5224814,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 43300,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,MIC,nM,1380.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,1.38
58675,,24976592,CHEMBL5224815,Antibacterial activity against vancomycin intermediate and methicillin resistant Staphylococcus aureus ATCC 700698,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,MIC,nM,22140.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,22.14
58676,,24976617,CHEMBL5224816,Antibacterial activity against vancomycin intermediate and methicillin resistant Staphylococcus aureus ATCC 700699,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,MIC,nM,22140.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,22.14
58677,,24976635,CHEMBL5224817,Antibacterial activity against methicillin sensitive Staphylococcus aureus 20-12,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,MIC,nM,1380.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,1.38
58678,,24976653,CHEMBL5224818,Antibacterial activity against methicillin sensitive Staphylococcus aureus ATCC 33591,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,MIC,nM,690.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.69
58679,,24976671,CHEMBL5224819,Antibacterial activity against methicillin resistant Staphylococcus aureus 18-2,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,MIC,nM,177100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,177.1
58680,,24976685,CHEMBL5224820,Antibacterial activity against Vanomycin-resistant Enterococcus faecalis ATCC 51299,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,MIC,nM,1380.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,uM,UO_0000065,1.38
58681,,24976699,CHEMBL5224821,Antibacterial activity against Vanomycin-resistant Enterococcus faecalis ATCC 51575,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,MIC,nM,2770.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,uM,UO_0000065,2.77
58682,,24976713,CHEMBL5224822,Antibacterial activity against Vanomycin-resistant Enterococcus faecium ATCC 700221,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,MIC,nM,177100.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,uM,UO_0000065,177.1
58683,,24976727,CHEMBL5224823,Antibacterial activity against Vanomycin-resistant Enterococcus faecium ATCC 51559,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,MIC,nM,88550.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,uM,UO_0000065,88.55
58684,,24976741,CHEMBL5224824,Antibacterial activity against Vanomycin-resistant Enterococcus faecium 15-6,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5223117,Bioorg Med Chem Lett,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3903299,=,1,1,=,MIC,nM,177100.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,uM,UO_0000065,177.1
58685,,24983353,CHEMBL5226740,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5226286,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905373,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
58686,,24983357,CHEMBL5226741,Antibacterial activity against Pseudomonas aeruginosa No.010,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5226286,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905373,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
58687,,24983361,CHEMBL5226742,Antibacterial activity against multidrug resistant Pseudomonas aeruginosa 025,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5226286,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905373,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
58688,,24983365,CHEMBL5226743,Antibacterial activity against multidrug resistant Pseudomonas aeruginosa 034,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5226286,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905373,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
58689,,24996143,CHEMBL5231788,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth incubated for 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5230129,Eur J Med Chem,2020.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3909493,=,1,1,=,MIC,ug.mL-1,3.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,3.12
58690,,25000635,CHEMBL5232888,Antibacterial activity against Mycobacterium smegmatis ATCC 607 assessed as inhibition of bacterial growth incubated for 2 days by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5230166,RSC Med Chem,2023.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911004,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC,ug ml-1,UO_0000274,0.125
58691,,25000664,CHEMBL5232889,Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as inhibition of bacterial growth incubated for 2 days by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5230166,RSC Med Chem,2023.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911004,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,2.0
58692,,25000693,CHEMBL5232890,Antibacterial activity multi-drug resistant Mycobacterium tuberculosis H37Rv ATCC 35822 assessed as inhibition of bacterial growth incubated for 2 days by CLSI protocol based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5230166,RSC Med Chem,2023.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911004,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,4.0
58693,,25019290,CHEMBL5239023,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC BAA-1556 incubated for 24 hrs by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5236607,J Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3916301,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
58694,,25019301,CHEMBL5239024,Antibacterial activity against Pseudomonas aeruginosa ATCC 27883 incubated for 24 hrs by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5236607,J Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3916301,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
58695,,25019312,CHEMBL5239025,Antibacterial activity against Escherichia coli ATCC 25922 incubated for 24 hrs by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5236607,J Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3916301,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
58696,,25019323,CHEMBL5239026,Antibacterial activity against Klebsiella pneumoniae ATCC BAA-1705 incubated for 24 hrs by checkerboard assay,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5236607,J Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3916301,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
58697,,25029984,CHEMBL5241345,Antimicrobial activity against Methicillin sensitive Staphylococcus aureus assessed as bacterial growth inhibition incubated for 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5241058,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3918735,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58698,,25032864,CHEMBL5242341,Antibacterial activity against quinolone susceptible Pseudomonas aeruginosa,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5241092,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919819,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.015
58699,,25032868,CHEMBL5242342,Antibacterial activity against quinolone susceptible Escherichia coli,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5241092,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919819,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
58700,,25032871,CHEMBL5242343,Antibacterial activity against quinolone resistant Pseudomonas aeruginosa,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5241092,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919819,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
58701,,25032874,CHEMBL5242344,Antibacterial activity against quinolone resistant Escherichia coli,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5241092,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919819,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
58702,,25032878,CHEMBL5242345,Antibacterial activity against quinolone resistant Acinetobacter baumannii,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5241092,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919819,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,4.0
58703,,25032957,CHEMBL5242368,Antibacterial activity against Clostridioides difficile,F,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5241092,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919819,=,1,1,=,MIC50,ug.mL-1,128.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC50,ug ml-1,UO_0000274,128.0
58704,,25032958,CHEMBL5242368,Antibacterial activity against Clostridioides difficile,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5241092,Eur J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919819,>,1,1,>,MIC90,ug.mL-1,128.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC90,ug ml-1,UO_0000274,128.0
58705,,25035602,CHEMBL5243164,Antimicrobial activity against Escherichia coli assessed as diameter of inhibition zone by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5241112,RSC Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,3920774,=,1,1,=,IZ,mm,29.35,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,29.35
58706,,25035604,CHEMBL5243165,Antimicrobial activity against Bacillus subtilis assessed as diameter of inhibition zone by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5241112,RSC Med Chem,2022.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Millimeter,3920774,=,1,1,=,IZ,mm,26.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,DIZ,mm,UO_0000016,26.0
58707,,25040083,CHEMBL5244529,Antimalarial activity against hepatic stage Plasmodium yoelii yoelii 265 BY for 48 hrs with media renew every 24 hrs,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922442,>,1,1,>,IC50,ug.mL-1,100.0,CHEMBL612328,Plasmodium yoelii yoelii,Plasmodium yoelii yoelii,73239.0,,IC50,ug ml-1,UO_0000274,100.0
58708,,25040108,CHEMBL5244530,Antimalarial activity against blood stage chloroquine-sensitive Plasmodium falciparum NF54-R infected in erythrocytes assessed as reduction in parasite growth preincubated for 72 hrs followed by addition of [3H]Hypoxanthine and measured after 24 hrs by liquid scintillation counting method,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922442,=,1,1,=,IC50,ug.mL-1,40.3,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ug ml-1,UO_0000274,40.3
58709,,25040134,CHEMBL5244531,Antimalarial activity against blood stage chloroquine-sensitive Plasmodium falciparum 3D7 infected in erythrocytes assessed as reduction in parasite growth preincubated for 72 hrs followed by addition of [3H]Hypoxanthine and measured after 24 hrs by liquid scintillation counting method,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922442,=,1,1,=,IC50,ug.mL-1,111.6,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ug ml-1,UO_0000274,111.6
58710,,25040205,CHEMBL5244554,Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human erythrocyte incubated for 72 hrs by SYBR green I staining based fluorescence assay,F,BAO_0000190,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5244209,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3922442,>,1,1,>,IC50,nM,20000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,nM,UO_0000065,20000.0
58711,,25040701,CHEMBL5244788,Antimicrobial activity against methicillin-resistant Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5244218,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922835,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
58712,,25040712,CHEMBL5244791,Antimicrobial activity against methicillin-resistant Staphylococcus aureus incubated for 18 hrs by Alamar blue staining based analysis,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5244218,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922835,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58713,,25040748,CHEMBL5244793,Antimicrobial activity against methicillin-resistant Staphylococcus aureus incubated for 18 hrs by Agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5244218,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922835,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
58714,,25040775,CHEMBL5244797,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolates by two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5244218,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922835,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.56
58715,,25040865,CHEMBL5244812,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolates by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5244218,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922835,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
58716,,25041136,CHEMBL5244855,Antibacterial activity against Escherichia coli 2010-05 assessed as bacterial growth inhibition measured after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5244219,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922898,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
58717,,25041146,CHEMBL5244856,Antibacterial activity against Escherichia coli 2010-29 assessed as bacterial growth inhibition measured after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5244219,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922898,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
58718,,25041153,CHEMBL5244860,Inhibition of Escherichia coli DNA gyrase,B,BAO_0000190,BAO_0000223,protein complex format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5244219,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922898,=,1,1,=,IC50,ug.mL-1,3.2,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,IC50,ug ml-1,UO_0000274,3.2
58719,,25041321,CHEMBL5244893,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5244219,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922898,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,4.0
58720,,25041325,CHEMBL5244894,Antibacterial activity against clinical isolate Escherichia coli assessed as bacterial growth inhibition incubated for 24 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5244219,Eur J Med Chem,2018.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922898,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,32.0
58721,,25049782,CHEMBL5246946,Antibacterial activity against methicillin susceptible Staphylococcus aureus ATCC 29213,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5244273,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925677,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
58722,,25049784,CHEMBL5246947,Antibacterial activity against ESBL negative Escherichia coli ATCC 25922,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5244273,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925677,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
58723,,25049786,CHEMBL5246948,Antibacterial activity against Staphylococcus epidermidis,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5244273,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925677,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
58724,,25049788,CHEMBL5246949,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 2 weeks,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5244273,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925677,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.25
58725,,25049811,CHEMBL5246950,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 3 weeks,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5244273,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925677,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.25
58726,,25049834,CHEMBL5246951,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 4 weeks,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5244273,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925677,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.25
58727,,25049857,CHEMBL5246952,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 5 weeks,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5244273,J Med Chem,2021.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3925677,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.25
58728,,25065675,CHEMBL5251416,Antibacterial activity against multi-drug resistant Acinetobacter baumannii assessed as bacterial growth inhibition by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5247650,J Med Chem,2023.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3928733,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,16.0
58729,,25065681,CHEMBL5251417,Antibacterial activity against non multi-drug resistant Acinetobacter baumannii assessed as bacterial growth inhibition by CLSI based broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5247650,J Med Chem,2023.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3928733,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,16.0
58730,,25065696,CHEMBL5251425,Antibacterial activity against clinical isolate Acinetobacter baumannii assessed as bacterial growth inhibition at 32 ug/ml by CLSI based broth microdilution method relative to control,F,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5247650,J Med Chem,2023.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://qudt.org/vocab/unit#Percent,3928733,=,1,1,=,Inhibition,%,100.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,INH,%,UO_0000187,100.0
58731,,25072318,CHEMBL5253313,Antibacterial activity against wild type Staphylococcus aureus incubated for 20 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5252521,Bioorg Med Chem,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929953,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
58732,,25072323,CHEMBL5253315,Antibacterial activity against methicillin-resistant Staphylococcus aureus incubated for 20 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5252521,Bioorg Med Chem,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929953,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
58733,,25072326,CHEMBL5253316,Antibacterial activity against wild type Streptococcus pneumoniae incubated for 20 hrs in presence of 2.5% lysed horse blood by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5252521,Bioorg Med Chem,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929953,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
58734,,25072329,CHEMBL5253317,Antibacterial activity against vancomycin-resistant Enterococcus faecium incubated for 20 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5252521,Bioorg Med Chem,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929953,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,4.0
58735,,25072334,CHEMBL5253320,Antibacterial activity against wild type Moraxella catarrhalis incubated for 20 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5252521,Bioorg Med Chem,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929953,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC,ug ml-1,UO_0000274,1.0
58736,,25072337,CHEMBL5253321,Antibacterial activity against wild type Haemophilus influenzae incubated for 20 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5252521,Bioorg Med Chem,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929953,<,1,1,<,MIC,ug.mL-1,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.015
58737,,25072340,CHEMBL5253322,Antibacterial activity against wild type Escherichia coli incubated for 20 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5252521,Bioorg Med Chem,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929953,=,1,1,=,MIC,ug.mL-1,0.031,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.031
58738,,25072343,CHEMBL5253323,Antibacterial activity against wild type Pseudomonas aeruginosa incubated for 20 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5252521,Bioorg Med Chem,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929953,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
58739,,25072346,CHEMBL5253324,Antibacterial activity against wild type Acinetobacter baumannii incubated for 20 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5252521,Bioorg Med Chem,2016.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3929953,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.125
58740,,25103808,CHEMBL5262789,Antimycobacterial activity against Mycobacterium tuberculosis Rv0005 harbouring gyrB gene,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5260811,Eur J Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3936459,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.5
58741,,25103813,CHEMBL5262790,Antimycobacterial activity against Mycobacterium tuberculosis Rv0006 harbouring gyrA gene,F,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5260811,Eur J Med Chem,2017.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3936459,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.5
58742,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25120019,CHEMBL5291755,Compound was evaluated for inhibition of rat Cacna1c in an in vitro assay with cellular components measured by membrane filtration,F,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5291721,Nat Commun,2023.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,AC50,nM,10000.0,CHEMBL3762,Rattus norvegicus,Voltage-gated L-type calcium channel alpha-1C subunit,10116.0,,AC50,uM,UO_0000065,10.0
58743,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25121120,CHEMBL5291805,Binding affinity towards rat Grin1 in an in vitro assay with cellular components measured by membrane filtration,B,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5291721,Nat Commun,2023.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,AC50,nM,10000.0,CHEMBL330,Rattus norvegicus,Glutamate (NMDA) receptor subunit zeta 1,10116.0,,AC50,uM,UO_0000065,10.0
58744,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25128521,CHEMBL5291798,Binding affinity towards rat Gabra1 in an in vitro assay with cellular components measured by membrane filtration,B,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5291721,Nat Commun,2023.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,AC50,nM,10000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,AC50,uM,UO_0000065,10.0
58745,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25131136,CHEMBL5291801,Compound was evaluated for inhibition of rat Gabra1 in an in vitro assay with cellular components measured by membrane filtration,F,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5291721,Nat Commun,2023.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,AC50,nM,10000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,AC50,uM,UO_0000065,10.0
58746,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25174934,CHEMBL5291868,Compound was evaluated for inhibition of rat Ptgs1 in an in vitro cell free assay measured by fluorescence spectroscopy,F,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5291721,Nat Commun,2023.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,AC50,nM,30000.0,CHEMBL4042,Rattus norvegicus,Cyclooxygenase-1,10116.0,,AC50,uM,UO_0000065,30.0
58747,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25187745,CHEMBL5291748,Binding affinity towards rat Ar in an in vitro cell free assay measured by fluorescence polarization method,B,BAO_0000186,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,CHEMBL5291721,Nat Commun,2023.0,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,0,http://www.openphacts.org/units/Nanomolar,3940568,>,1,1,>,AC50,nM,30000.0,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,AC50,uM,UO_0000065,30.0
58748,,383854,CHEMBL762013,In vitro inhibition of multidrug-resistant Plasmodium falciparum K1,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1152011,Bioorg Med Chem Lett,1994.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,73316,=,1,1,=,IC50,ug.mL-1,0.36,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ug ml-1,UO_0000274,0.36
58749,,1251234,CHEMBL754059,In vitro antimalarial activity against Plasmodium falciparum D6,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1124122,J Med Chem,1988.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,9629,=,1,1,=,IC50,ug.mL-1,0.141,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ng ml-1,UO_0000274,141.0
58750,,1251235,CHEMBL753350,In vitro antimalarial activity against Plasmodium falciparum W2,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1124122,J Med Chem,1988.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,9629,=,1,1,=,IC50,ug.mL-1,0.148,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,ng ml-1,UO_0000274,148.0
58751,,1692684,CHEMBL868373,Antibacterial activity against Escherichia coli,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1139034,Bioorg Med Chem Lett,2006.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,440358,=,1,1,=,MIC,ug.mL-1,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,5.0
58752,,1759174,CHEMBL866699,Antifungal activity against Cryptococcus neoformans ATCC 36556 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1146003,Bioorg Med Chem Lett,2006.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,536536,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,MIC,ug ml-1,UO_0000274,64.0
58753,,1759175,CHEMBL866698,Antifungal activity against Aspergillus terreus ATCC 46941 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1146003,Bioorg Med Chem Lett,2006.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,536536,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL612277,Aspergillus terreus,Aspergillus terreus,33178.0,,MIC,ug ml-1,UO_0000274,128.0
58754,,1759176,CHEMBL866164,Antifungal activity against Aspergillus fumigatus ATCC 16424 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1146003,Bioorg Med Chem Lett,2006.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,536536,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL363,Aspergillus fumigatus,Aspergillus fumigatus,746128.0,,MIC,ug ml-1,UO_0000274,128.0
58755,,1759177,CHEMBL866163,Antifungal activity against Candida krusei ATCC 6258 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1146003,Bioorg Med Chem Lett,2006.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,536536,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL612841,Pichia kudriavzevii,Pichia kudriavzevii,4909.0,,MIC,ug ml-1,UO_0000274,32.0
58756,,1759178,CHEMBL866162,Antifungal activity against Candida lusitaniae ATCC 42720 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1146003,Bioorg Med Chem Lett,2006.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,536536,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL612362,Clavispora lusitaniae,Clavispora lusitaniae,36911.0,,MIC,ug ml-1,UO_0000274,128.0
58757,,1759179,CHEMBL866161,Antifungal activity against Candida tropicalis ATCC 13803 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1146003,Bioorg Med Chem Lett,2006.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,536536,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL612870,Candida tropicalis,Candida tropicalis,5482.0,,MIC,ug ml-1,UO_0000274,16.0
58758,,1759180,CHEMBL866160,Antifungal activity against Candida albicans ATCC 10231 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1146003,Bioorg Med Chem Lett,2006.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,536536,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,128.0
58759,,1958259,CHEMBL890913,Antiviral activity against HCMV in MRC5 cells by plaque reduction assay,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1146376,Bioorg Med Chem Lett,2007.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,648146,=,1,1,=,IC50,nM,680.0,CHEMBL371,Human betaherpesvirus 5,Human betaherpesvirus 5,10359.0,,IC50,uM,UO_0000065,0.68
58760,Active,1958363,CHEMBL890915,Inhibition of HCMV proliferation in MRC5 cells after 54 hrs post-infection at 10 uM by plaque assay,F,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1146376,Bioorg Med Chem Lett,2007.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,648146,,1,0,,Activity,,,CHEMBL371,Human betaherpesvirus 5,Human betaherpesvirus 5,10359.0,,Activity,,,
58761,Active,1958364,CHEMBL890916,Inhibition of HCMV proliferation in MRC5 cells after 24 hrs post-infection at 10 uM by plaque assay,F,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1146376,Bioorg Med Chem Lett,2007.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,648146,,1,0,,Activity,,,CHEMBL371,Human betaherpesvirus 5,Human betaherpesvirus 5,10359.0,,Activity,,,
58762,Not Active,1958365,CHEMBL890917,Inhibition of HCMV adsorption to MRC5 cells at 0.2 to 2 uM by infectious centre assay,F,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1146376,Bioorg Med Chem Lett,2007.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,648146,,1,0,,Activity,,,CHEMBL371,Human betaherpesvirus 5,Human betaherpesvirus 5,10359.0,,Activity,,,
58763,Not Active,1958366,CHEMBL890918,Inhibition of HCMV penetration to MRC5 cells at 0.2 to 2 uM,F,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1146376,Bioorg Med Chem Lett,2007.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,648146,,1,0,,Activity,,,CHEMBL371,Human betaherpesvirus 5,Human betaherpesvirus 5,10359.0,,Activity,,,
58764,,1974834,CHEMBL898573,Inhibition of amplification in human telo21 G-quadruplex DNA by PCR stop assay,B,BAO_0000190,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1149624,Bioorg Med Chem,2007.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,659677,=,1,1,=,IC50,nM,2100.0,CHEMBL612545,,Unchecked,,,IC50,umol/L,UO_0000065,2.1
58765,,1974842,CHEMBL898574,Inhibition of telomerase expressed in MCF7 cells by TRAP assay,B,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1149624,Bioorg Med Chem,2007.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,659677,=,1,1,=,IC50,nM,75000.0,CHEMBL612545,,Unchecked,,,IC50,umol/L,UO_0000065,75.0
58766,,1974850,CHEMBL898572,Binding affinity to human telo21 G-quadruplex DNA at 1 uM after 5 mins,B,BAO_0000192,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1149624,Bioorg Med Chem,2007.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,659677,=,1,1,=,Ki,nM,1790.0,CHEMBL612545,,Unchecked,,,Ki,10^-6/M,UO_0000065,1.79
58767,,1981662,CHEMBL899225,Inhibition of SrtA,B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1149701,Bioorg Med Chem Lett,2007.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,661495,=,1,1,=,IC50,ug.mL-1,8.7,CHEMBL5362,Staphylococcus aureus,Sortase A,1280.0,,IC50,ug ml-1,UO_0000274,8.7
58768,,1981667,CHEMBL899226,Antimicrobial activity against Staphylococcus aureus Newman,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1149701,Bioorg Med Chem Lett,2007.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,661495,=,1,1,=,MIC,ug.mL-1,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,100.0
58769,Active,2178422,CHEMBL966379,Antimicrobial activity against Staphylococcus aureus 4222 with norA KLE mutation at 120 to 140 ug/ml,F,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1155570,J Nat Prod,2000.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,712189,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
58770,,2191325,CHEMBL975031,Cytotoxicity against Sprague-Dawley rat primary hepatocytes after 24 hrs by MTT assay,A,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1157160,Bioorg Med Chem,2008.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,741418,=,1,1,=,IC50,ug.mL-1,26.5,CHEMBL613362,Rattus norvegicus,Hepatocyte,10116.0,,IC50,ug ml-1,UO_0000274,26.5
58771,,2274072,CHEMBL1030753,Inhibition of 6-His tagged Staphylococcus aureus recombinant sortase delta N24 expressed in Escherichia coli BL21 (DE3),B,BAO_0000190,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1153353,Bioorg Med Chem,2009.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,1,http://www.openphacts.org/units/MicrogramPerMilliliter,755347,=,1,1,=,IC50,ug.mL-1,8.7,CHEMBL5362,Staphylococcus aureus,Sortase A,1280.0,,IC50,ug ml-1,UO_0000274,8.7
58772,,2297763,CHEMBL1018093,Inhibition of HIV1 RT,B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1137798,J Nat Prod,1991.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,811338,=,1,1,=,IC50,ug.mL-1,100.0,CHEMBL247,Human immunodeficiency virus 1,Human immunodeficiency virus type 1 reverse transcriptase,11676.0,,IC50,ug ml-1,UO_0000274,100.0
58773,,2322510,CHEMBL1004277,Antifungal activity against Candida albicans IFO 1061 after 48 hrs by serial broth dilution test,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1150950,J Nat Prod,1998.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,787654,=,1,1,=,MIC,ug.mL-1,500.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,500.0
58774,,2322523,CHEMBL1004276,Antibacterial activity against Escherichia coli IFO 026 after 24 hrs by serial broth dilution test,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1150950,J Nat Prod,1998.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,787654,>,1,1,>,MIC,ug.mL-1,2000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2000.0
58775,,2322536,CHEMBL1004275,Antibacterial activity against Salmonella enteritidis after 24 hrs by serial broth dilution test,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1150950,J Nat Prod,1998.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,787654,=,1,1,=,MIC,ug.mL-1,500.0,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,MIC,ug ml-1,UO_0000274,500.0
58776,,2322549,CHEMBL1004274,Antibacterial activity against Bacillus subtilis after 24 hrs by serial broth dilution test,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1150950,J Nat Prod,1998.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,787654,=,1,1,=,MIC,ug.mL-1,1000.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,1000.0
58777,,2322562,CHEMBL1004273,Antibacterial activity against Staphylococcus aureus after 24 hrs by serial broth dilution test,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1150950,J Nat Prod,1998.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,787654,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,250.0
58778,,2322589,CHEMBL1003436,Antimicrobial activity against recombinant Mycobacterium bovis BCG expressing pMV361 lux after 5 days by luciferase assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1150956,J Nat Prod,1998.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,787822,=,1,1,=,MIC,ug.mL-1,200.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,200.0
58779,,2322597,CHEMBL1003437,Antimicrobial activity against recombinant Mycobacterium intracellular expressing pMV361 lux after 3 days by luciferase assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1150956,J Nat Prod,1998.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,787822,=,1,1,=,MIC,ug.mL-1,200.0,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,MIC,ug ml-1,UO_0000274,200.0
58780,,2322635,CHEMBL1003429,Antimicrobial activity against Staphylococcus aureus ATCC 13709,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1150956,J Nat Prod,1998.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,787822,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,50.0
58781,,2322636,CHEMBL1003432,Antimicrobial activity against Klebsiella pneumoniae ATCC 10031,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1150956,J Nat Prod,1998.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,787822,=,1,1,=,MIC,ug.mL-1,100.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,100.0
58782,,2322637,CHEMBL1003433,Antimicrobial activity against Mycobacterium smegmatis ATCC 607,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1150956,J Nat Prod,1998.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,787822,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC,ug ml-1,UO_0000274,25.0
58783,,2322638,CHEMBL1003434,Antimicrobial activity against Candida albicans ATCC 10231,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1150956,J Nat Prod,1998.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,787822,=,1,1,=,MIC,ug.mL-1,100.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,100.0
58784,,2389912,CHEMBL950528,"Reduction of blood cholesterol level in hyperlipidemic Sprague-Dawley rat at 100 mg/kg, po daily twice for 30 days relative to control",F,BAO_0001103,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1140862,J Med Chem,2009.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://qudt.org/vocab/unit#Percent,729195,=,1,0,=,Activity,%,27.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Activity,%,UO_0000187,27.4
58785,,2389913,CHEMBL950529,"Reduction of blood low density lipoprotein cholesterol level in hyperlipidemic Sprague-Dawley rat at 100 mg/kg, po daily twice for 30 days relative to control",F,BAO_0001103,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1140862,J Med Chem,2009.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://qudt.org/vocab/unit#Percent,729195,=,1,0,=,Activity,%,31.6,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Activity,%,UO_0000187,31.6
58786,tde,2389918,CHEMBL950530,"Reduction of blood cholesterol level in hyperlipidemic Sprague-Dawley rat at 100 mg/kg, po daily twice",F,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1140862,J Med Chem,2009.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,729195,,1,0,,Activity,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Activity,,,
58787,tde,2389919,CHEMBL950531,"Reduction of blood low density lipoprotein cholesterol level in hyperlipidemic Sprague-Dawley rat at 100 mg/kg, po daily twice",F,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1140862,J Med Chem,2009.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,729195,,1,0,,Activity,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Activity,,,
58788,,2389921,CHEMBL950532,"Induction of LDLR mRNA expression in hyperlipidemic Sprague-Dawley rat liver at 100 mg/kg, po daily twice for 30 days by RT-PCR relative to control",F,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1140862,J Med Chem,2009.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,729195,=,1,0,=,FC,,1.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,FC,,,1.5
58789,Not Active,2389922,CHEMBL951473,"Induction of HMG-CoA reductase mRNA expression in hyperlipidemic Sprague-Dawley rat liver at 100 mg/kg, po daily twice for 30 days by RT-PCR",F,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1140862,J Med Chem,2009.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,729195,,1,0,,Activity,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Activity,,,
58790,,2429808,CHEMBL998453,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 1126 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1148941,J Nat Prod,2004.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,762102,=,1,1,=,MIC,ug.mL-1,60.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/ml,UO_0000274,0.06
58791,Not Determined,2442188,CHEMBL989439,Antioxidant activity assessed as DPPH radical scavenging activity,F,BAO_0000190,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1146568,J Nat Prod,2003.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,715571,,1,0,,IC50,,,CHEMBL613712,,Radical scavenging activity,,,IC50,,,
58792,,2546143,CHEMBL968123,Antiplasmodial activity against multi drug-resistant Plasmodium falciparum K1 in erythrocytes by [3H]hypoxanthine uptake,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1155642,J Nat Prod,2000.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,736158,=,1,1,=,IC50,nM,968.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,0.968
58793,,2546165,CHEMBL968124,Antiamnesic activity against Entamoeba histolytica NIH 200 after 72 hrs by microdilution technique,F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1155642,J Nat Prod,2000.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,736158,=,1,1,=,IC50,nM,111000.0,CHEMBL612853,Entamoeba histolytica,Entamoeba histolytica,5759.0,,IC50,uM,UO_0000065,111.0
58794,,2549652,CHEMBL977556,Antifungal activity against wild type Candida albicans Al-1 after 48 hrs by NCCLS M27A method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1142598,J Nat Prod,2006.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,786871,=,1,1,=,MIC,ug.mL-1,31.3,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,31.3
58795,,2549655,CHEMBL977557,Antifungal activity against azole-resistant Candida albicans D10 after 48 hrs by NCCLS M27A method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1142598,J Nat Prod,2006.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,786871,=,1,1,=,MIC,ug.mL-1,31.3,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,31.3
58796,,2549659,CHEMBL977558,Antifungal activity against azole-resistant Candida albicans CN1A after 48 hrs by NCCLS M27A method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1142598,J Nat Prod,2006.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,786871,=,1,1,=,MIC,ug.mL-1,15.6,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,15.6
58797,,2549663,CHEMBL977560,Antifungal activity against Candida shehatae after 48 hrs by NCCLS M27A method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1142598,J Nat Prod,2006.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,786871,=,1,1,=,MIC,ug.mL-1,7.8,CHEMBL613933,Scheffersomyces shehatae,Scheffersomyces shehatae,45589.0,,MIC,ug ml-1,UO_0000274,7.8
58798,,2549664,CHEMBL977559,Antifungal activity against Cryptococcus neoformans after 48 hrs by NCCLS M27A method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1142598,J Nat Prod,2006.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,786871,=,1,1,=,MIC,ug.mL-1,31.3,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,MIC,ug ml-1,UO_0000274,31.3
58799,,2549665,CHEMBL966449,Antifungal activity against Saccharomyces cerevisiae after 48 hrs by NCCLS M27A method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1142598,J Nat Prod,2006.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,786871,=,1,1,=,MIC,ug.mL-1,78.1,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,MIC,ug ml-1,UO_0000274,78.1
58800,,2549666,CHEMBL980221,Antifungal activity against filamentous Wangiella dermatitidis after 48 hrs by NCCLS M27A method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1142598,J Nat Prod,2006.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,786871,=,1,1,=,MIC,ug.mL-1,31.3,CHEMBL612740,Exophiala dermatitidis,Exophiala dermatitidis,5970.0,,MIC,ug ml-1,UO_0000274,31.3
58801,,2549667,CHEMBL980222,Antifungal activity against Pseudallescheria boydii after 48 hrs by NCCLS M27A method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1142598,J Nat Prod,2006.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,786871,=,1,1,=,MIC,ug.mL-1,62.5,CHEMBL612876,Scedosporium boydii,Scedosporium boydii,5597.0,,MIC,ug ml-1,UO_0000274,62.5
58802,,2549668,CHEMBL980223,Antifungal activity against Alternaria alternata after 48 hrs by NCCLS M27A method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1142598,J Nat Prod,2006.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,786871,=,1,1,=,MIC,ug.mL-1,125.0,CHEMBL613794,Alternaria alternata,Alternaria alternata,5599.0,,MIC,ug ml-1,UO_0000274,125.0
58803,,2549669,CHEMBL980224,Antifungal activity against wild type Candida albicans Al-1 in presence of dillapiol,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1142598,J Nat Prod,2006.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,786871,=,1,1,=,MIC,ug.mL-1,15.6,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,15.6
58804,,2549670,CHEMBL980225,Potentiation of drimane-type sesquiterpene-induced antifungal activity against wild type Candida albicans Al-1 assessed as fractional inhibition concentration index,F,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1142598,J Nat Prod,2006.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,786871,=,1,0,=,FICI,,0.5,CHEMBL366,Candida albicans,Candida albicans,5476.0,,FICI,,,0.5
58805,,2551628,CHEMBL969218,Antimicrobial activity against wild-type Staphylococcus aureus 8325-4,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1157254,J Nat Prod,2006.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,759759,=,1,1,=,MIC,nM,372000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,372.0
58806,,2551629,CHEMBL969217,Antimicrobial activity against NorA knockout Staphylococcus aureus K1758 mutant,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1157254,J Nat Prod,2006.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,759759,=,1,1,=,MIC,nM,89000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,89.0
58807,,2551630,CHEMBL969220,Antimicrobial activity against Staphylococcus aureus K2361 mutant overexpressing NorA,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1157254,J Nat Prod,2006.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,759759,=,1,1,=,MIC,nM,1488000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,1488.0
58808,,2571351,CHEMBL996994,Antibacterial activity against NorA knockout Staphylococcus aureus K1758 after 18 to 20 hrs by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1155887,Bioorg Med Chem Lett,2008.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,769608,=,1,1,=,MIC,nM,67000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,67.0
58809,,2571352,CHEMBL996995,Antibacterial activity against wild type Staphylococcus aureus 8325-4 after 18 to 20 hrs by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1155887,Bioorg Med Chem Lett,2008.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,769608,=,1,1,=,MIC,nM,269000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,269.0
58810,,2571353,CHEMBL996996,Antibacterial activity against Staphylococcus aureus K2378 overexpressing NorA after 18 to 20 hrs by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1155887,Bioorg Med Chem Lett,2008.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,769608,=,1,1,=,MIC,nM,2152000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,2152.0
58811,,2655868,CHEMBL1032727,Antibacterial activity against Staphylococcus aureus K1758 NorA efflux pump-deficient mutant after 18 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1158423,Bioorg Med Chem,2009.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,816041,=,1,1,=,MIC,nM,40000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,40.0
58812,,2655875,CHEMBL1032728,Antibacterial activity against wild type Staphylococcus aureus 8325-4 after 18 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1158423,Bioorg Med Chem,2009.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,816041,=,1,1,=,MIC,nM,325000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,325.0
58813,,2655882,CHEMBL1032729,Antibacterial activity against Staphylococcus aureus K2378 overexpressing NorA efflux pump after 18 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1158423,Bioorg Med Chem,2009.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,816041,>,1,1,>,MIC,nM,650000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,650.0
58814,,2655889,CHEMBL1032730,Antibacterial activity against Escherichia coli BW-25116 TolC-deficient mutant after 18 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1158423,Bioorg Med Chem,2009.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,816041,=,1,1,=,MIC,nM,325000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,325.0
58815,,2655896,CHEMBL1032731,Antibacterial activity against Escherichia coli ECM116 mar1642 overexpressing ArcAB pump after 18 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1158423,Bioorg Med Chem,2009.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,816041,=,1,1,=,MIC,nM,325000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,325.0
58816,,2655903,CHEMBL1032732,Antibacterial activity against Escherichia coli K-12 after 18 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1158423,Bioorg Med Chem,2009.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,816041,>,1,1,>,MIC,nM,2600000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,2600.0
58817,,2655910,CHEMBL1032733,Antibacterial activity against Escherichia coli ECM1642 after 18 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1158423,Bioorg Med Chem,2009.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,816041,>,1,1,>,MIC,nM,2600000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,2600.0
58818,,2655917,CHEMBL1032734,Antibacterial activity against Enterococcus faecalis OG1RF after 18 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1158423,Bioorg Med Chem,2009.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,816041,=,1,1,=,MIC,nM,650000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,uM,UO_0000065,650.0
58819,,2655924,CHEMBL1032735,Antibacterial activity against Enterococcus faecalis MMH594 after 18 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1158423,Bioorg Med Chem,2009.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,816041,>,1,1,>,MIC,nM,650000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,uM,UO_0000065,650.0
58820,,2655931,CHEMBL1032736,Antibacterial activity against Enterococcus faecalis V583 after 18 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1158423,Bioorg Med Chem,2009.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,816041,>,1,1,>,MIC,nM,650000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,uM,UO_0000065,650.0
58821,,3042798,CHEMBL1040692,NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay,F,BAO_0000188,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1156829,Proc Natl Acad Sci U S A,2008.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,865461,=,3,1,=,EC50,nM,442.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,EC50,uM,UO_0000065,0.442
58822,,3043651,CHEMBL1040691,NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ,F,BAO_0000188,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1156829,Proc Natl Acad Sci U S A,2008.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,865461,=,3,1,=,EC50,nM,218.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,EC50,uM,UO_0000065,0.218
58823,,3103971,CHEMBL1071733,Inhibition of electric eel AChE by modified Ellman method,B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1159112,Bioorg Med Chem,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,885080,=,1,1,=,IC50,nM,374.0,CHEMBL4078,Electrophorus electricus,Acetylcholinesterase,8005.0,,IC50,uM,UO_0000065,0.374
58824,,3105075,CHEMBL1071734,Inhibition of horse serum BChE by Ellman's method,B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1159112,Bioorg Med Chem,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,885080,=,1,1,=,IC50,nM,18200.0,CHEMBL5763,Equus caballus,Cholinesterase,9796.0,,IC50,uM,UO_0000065,18.2
58825,,3105077,CHEMBL1071735,Selectivity for electric eel AChE over horse serum BChE,B,BAO_0000179,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1159112,Bioorg Med Chem,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,885080,=,1,0,=,Ratio IC50,,48.6,CHEMBL612545,,Unchecked,,,Ratio IC50,,,48.6
58826,,3105094,CHEMBL1071736,Inhibition of electric eel AChE by enzyme kinetics assay,B,BAO_0000192,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1159112,Bioorg Med Chem,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,885080,=,1,1,=,Ki,nM,289.0,CHEMBL4078,Electrophorus electricus,Acetylcholinesterase,8005.0,,Ki,uM,UO_0000065,0.289
58827,,3105096,CHEMBL1071737,Inhibition of horse serum BChE by enzyme kinetics assay,B,BAO_0000192,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1159112,Bioorg Med Chem,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,885080,=,1,1,=,Ki,nM,9200.0,CHEMBL5763,Equus caballus,Cholinesterase,9796.0,,Ki,uM,UO_0000065,9.2
58828,Active,3105098,CHEMBL1071738,Non-competitive inhibition of electric eel AChE by Lineweaver-Burke plot,B,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1159112,Bioorg Med Chem,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://qudt.org/vocab/unit#Percent,885080,,1,0,,Inhibition,%,,CHEMBL4078,Electrophorus electricus,Acetylcholinesterase,8005.0,,INH,,UO_0000187,
58829,Active,3105100,CHEMBL1071740,Non-competitive inhibition of horse serum BChE by Lineweaver-Burke plot,B,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1159112,Bioorg Med Chem,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://qudt.org/vocab/unit#Percent,885080,,1,0,,Inhibition,%,,CHEMBL5763,Equus caballus,Cholinesterase,9796.0,,INH,,UO_0000187,
58830,,3334442,CHEMBL1167959,Inhibition of electric eel AChE by Ellman's assay,B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1165944,Bioorg Med Chem,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,1,http://www.openphacts.org/units/Nanomolar,919653,=,1,1,=,IC50,nM,374.0,CHEMBL4078,Electrophorus electricus,Acetylcholinesterase,8005.0,,IC50,uM,UO_0000065,0.374
58831,,3334472,CHEMBL1167960,Inhibition of equine serum BuChE by Ellman's method,B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1165944,Bioorg Med Chem,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,1,http://www.openphacts.org/units/Nanomolar,919653,=,1,1,=,IC50,nM,18200.0,CHEMBL5763,Equus caballus,Cholinesterase,9796.0,,IC50,uM,UO_0000065,18.2
58832,,3334502,CHEMBL1167961,Selectivity ratio of IC50 for equine serum BuChE to IC50 for electric eel AChE,U,BAO_0000179,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1165944,Bioorg Med Chem,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,919653,=,1,0,=,Ratio IC50,,48.6,CHEMBL612545,,Unchecked,,,Ratio IC50,,,48.6
58833,,3425941,CHEMBL1225424,"Hypolipidemic activity in high fat high cholesterol diet fed Wistar rat hyperlipidemic model assessed as reduction in total cholesterol 100 mg/kg, po qd for 28 days",F,BAO_0001103,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1221278,Bioorg Med Chem,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://qudt.org/vocab/unit#Percent,936699,=,1,0,=,Activity,%,27.4,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Activity,%,UO_0000187,27.4
58834,,3425962,CHEMBL1225423,"Hypolipidemic activity in high fat high cholesterol diet fed Wistar rat hyperlipidemic model assessed as reduction in LDL cholesterol 100 mg/kg, po qd for 28 days",F,BAO_0001103,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1221278,Bioorg Med Chem,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://qudt.org/vocab/unit#Percent,936699,=,1,0,=,Activity,%,38.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Activity,%,UO_0000187,38.0
58835,,3529668,CHEMBL1273968,Selectivity ratio of IC50 for equine BChE to IC50 for electric eel AChE,B,BAO_0000179,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1268919,Bioorg Med Chem Lett,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,967109,=,1,0,=,Ratio IC50,,48.6,CHEMBL612545,,Unchecked,,,Ratio IC50,,,48.6
58836,Not Determined,3529681,CHEMBL1273967,Inhibition of equine BChE after 15 mins by Ellman's method using butyrylcholine as substrate,B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1268919,Bioorg Med Chem Lett,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,967109,,1,0,,IC50,,,CHEMBL5077,Equus caballus,Butyrylcholinesterase,9796.0,,IC50,,,
58837,,3529694,CHEMBL1273966,Inhibition of equine BChE after 15 mins by Ellman's method using acetylcholine as substrate,B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1268919,Bioorg Med Chem Lett,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,967109,=,1,1,=,IC50,nM,18200.0,CHEMBL5077,Equus caballus,Butyrylcholinesterase,9796.0,,IC50,uM,UO_0000065,18.2
58838,,3529707,CHEMBL1273965,Inhibition of electric eel AChE after 15 mins by Ellman's method using acetylcholine as substrate,B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1268919,Bioorg Med Chem Lett,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,1,http://www.openphacts.org/units/Nanomolar,967109,=,1,1,=,IC50,nM,374.0,CHEMBL4078,Electrophorus electricus,Acetylcholinesterase,8005.0,,IC50,uM,UO_0000065,0.374
58839,Active,3539286,CHEMBL1285392,Binding affinity to Candida albicans CaCdr1p expressed in yeast AD1-8u,B,BAO_0000375,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1275276,Eur J Med Chem,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,970247,,1,0,,Activity,,,CHEMBL612545,,Unchecked,,,Activity,,,
58840,Not Active,3539352,CHEMBL1285394,Binding affinity to Candida albicans CaMdr1p expressed in yeast AD1-8u,B,BAO_0000375,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1275276,Eur J Med Chem,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,970247,,1,0,,Activity,,,CHEMBL612545,,Unchecked,,,Activity,,,
58841,,3539418,CHEMBL1285395,Antifungal activity against yeast AD1-8u expressing Candida albicans CaCdr1p by agar disk diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1275276,Eur J Med Chem,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://qudt.org/vocab/unit#Millimeter,970247,=,1,1,=,IZ,mm,5.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,IZ,cm,UO_0000016,0.5
58842,,3539484,CHEMBL1285393,Antifungal activity against yeast AD1-8u expressing Candida albicans CaMdr1p by agar disk diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1275276,Eur J Med Chem,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://qudt.org/vocab/unit#Millimeter,970247,=,1,1,=,IZ,mm,0.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,IZ,cm,UO_0000016,0.0
58843,Inconclusive,4201622,CHEMBL1614459,PUBCHEM_BIOASSAY: qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells. (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1042837,=,7,1,=,Potency,nM,82.0,CHEMBL612545,,Unchecked,,,Potency,um,UO_0000065,0.082
58844,Inconclusive,4287370,CHEMBL1614459,PUBCHEM_BIOASSAY: qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells. (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1264003,=,7,1,=,Potency,nM,231.1,CHEMBL612545,,Unchecked,,,Potency,um,UO_0000065,0.2311
58845,Not Active,4411266,CHEMBL1614234,PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium. (Class of assay: confirmatory) [Related pubchem assays: 901 ],F,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,Potency,nM,3981.1,CHEMBL1293238,Rattus norvegicus,Inositol monophosphatase 1,10116.0,,Potency,um,UO_0000065,3.9811
58846,Inconclusive,4588688,CHEMBL1614275,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ]",F,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1042837,=,7,1,=,Potency,nM,17740.7,CHEMBL1293234,Giardia intestinalis,"Putative fructose-1,6-bisphosphate aldolase",5741.0,,Potency,um,UO_0000065,17.7407
58847,Inconclusive,4605453,CHEMBL1614275,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ]",F,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1157909,=,7,1,=,Potency,nM,4456.3,CHEMBL1293234,Giardia intestinalis,"Putative fructose-1,6-bisphosphate aldolase",5741.0,,Potency,um,UO_0000065,4.4563
58848,Inconclusive,4635124,CHEMBL1613797,PUBCHEM_BIOASSAY: qHTS Assay for Anthrax Lethal Toxin Internalization. (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,Potency,nM,19952.6,CHEMBL4372,Bacillus anthracis,Anthrax lethal factor,1392.0,,Potency,um,UO_0000065,19.9526
58849,Inconclusive,4647033,CHEMBL1614530,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",F,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1264003,=,7,1,=,Potency,nM,11220.2,CHEMBL2026,Escherichia coli K-12,Beta-lactamase AmpC,83333.0,,Potency,um,UO_0000065,11.2202
58850,Inconclusive,4868954,CHEMBL1614218,PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells. (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1010458,=,7,1,=,Potency,nM,3981.1,CHEMBL612545,,Unchecked,,,Potency,um,UO_0000065,3.9811
58851,,5119563,CHEMBL1638723,Antibacterial activity against wild-type Staphylococcus aureus 8325-4 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1629702,Antimicrob Agents Chemother,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1313080,=,1,1,=,MIC,nM,325000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,325.0
58852,,5119564,CHEMBL1638724,Antibacterial activity against NorA-deficient Staphylococcus aureus K1758 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1629702,Antimicrob Agents Chemother,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1313080,=,1,1,=,MIC,nM,40000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,40.0
58853,,5119565,CHEMBL1638725,Antibacterial activity against Staphylococcus aureus K2378 overexpressing NorA after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1629702,Antimicrob Agents Chemother,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1313080,>,1,1,>,MIC,nM,650000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,650.0
58854,Active,5119575,CHEMBL1638738,Antibacterial activity against NorA-deficient Staphylococcus aureus K1758 after 18 hrs by two fold serial dilution method in presence of INF55,F,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1629702,Antimicrob Agents Chemother,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1313080,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
58855,Active,5119576,CHEMBL1638739,Inhibition of NorA in Staphylococcus aureus 8325-4 assessed as decrease in Berberine MIC,B,BAO_0000375,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1629702,Antimicrob Agents Chemother,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1313080,,1,0,,Activity,,,CHEMBL5114,Staphylococcus aureus,Quinolone resistance protein norA,1280.0,,Activity,,,
58856,Active,5119577,CHEMBL1638740,Inhibition of NorA in Staphylococcus aureus K2378 overexpressing NorA assessed as decrease in Berberine MIC,B,BAO_0000375,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1629702,Antimicrob Agents Chemother,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1313080,,1,0,,Activity,,,CHEMBL5114,Staphylococcus aureus,Quinolone resistance protein norA,1280.0,,Activity,,,
58857,Not Active,5119581,CHEMBL1638728,Inhibition of NorA in Staphylococcus aureus 8325-4 assessed as accumulation of compound at 3 uM by fluorescence assay,B,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1629702,Antimicrob Agents Chemother,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://qudt.org/vocab/unit#Percent,1313080,,1,0,,Inhibition,%,,CHEMBL5114,Staphylococcus aureus,Quinolone resistance protein norA,1280.0,,INH,,UO_0000187,
58858,Not Active,5119582,CHEMBL1638729,Inhibition of NorA in Staphylococcus aureus K2378 overexpressing NorA assessed as accumulation of compound at 3 uM by fluorescence assay,B,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1629702,Antimicrob Agents Chemother,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://qudt.org/vocab/unit#Percent,1313080,,1,0,,Inhibition,%,,CHEMBL5114,Staphylococcus aureus,Quinolone resistance protein norA,1280.0,,INH,,UO_0000187,
58859,Active,5119583,CHEMBL1638730,Inhibition of NorA in Staphylococcus aureus 8325-4 assessed as accumulation of Berberine at 3 uM by fluorescence assay in presence of INF55,B,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1629702,Antimicrob Agents Chemother,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://qudt.org/vocab/unit#Percent,1313080,,1,0,,Inhibition,%,,CHEMBL5114,Staphylococcus aureus,Quinolone resistance protein norA,1280.0,,INH,,UO_0000187,
58860,Active,5119584,CHEMBL1638731,Inhibition of NorA in Staphylococcus aureus K2378 overexpressing NorA assessed as accumulation of Berberine at 3 uM by fluorescence assay in presence of INF55,B,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1629702,Antimicrob Agents Chemother,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://qudt.org/vocab/unit#Percent,1313080,,1,0,,Inhibition,%,,CHEMBL5114,Staphylococcus aureus,Quinolone resistance protein norA,1280.0,,INH,,UO_0000187,
58861,Active,5119585,CHEMBL1638732,Inhibition of NorA in Staphylococcus aureus 8325-4 assessed as assessed as accumulation of compound at 3 uM by fluorescence assay,B,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1629702,Antimicrob Agents Chemother,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://qudt.org/vocab/unit#Percent,1313080,,1,0,,Inhibition,%,,CHEMBL5114,Staphylococcus aureus,Quinolone resistance protein norA,1280.0,,INH,,UO_0000187,
58862,Active,5119586,CHEMBL1638741,Cellular uptake in NorA-deficient Staphylococcus aureus K1758 assessed as accumulation of compound at 3 uM by fluorescence assay,A,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1629702,Antimicrob Agents Chemother,2010.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1313080,,1,0,,Drug uptake,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Drug uptake,,,
58863,,5212450,CHEMBL1680768,Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBADomeganorM plasmid containing Neisseria gonorrhoeae multidrug efflux pump NorM after 18 to 24 hrs by two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1671618,Antimicrob Agents Chemother,2008.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331765,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,250.0
58864,,5212451,CHEMBL1680772,Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBADomegaydhE plasmid containing Escherichia coli multidrug efflux pump YdhE after 18 to 24 hrs by two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1671618,Antimicrob Agents Chemother,2008.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331765,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,250.0
58865,,5212452,CHEMBL1680771,Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBAD plasmid after 18 to 24 hrs by two fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1671618,Antimicrob Agents Chemother,2008.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331765,=,1,1,=,MIC,ug.mL-1,31.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,31.25
58866,inconclusive,5396415,CHEMBL1737994,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504444]",F,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,Potency,nM,25929.0,CHEMBL612545,,Unchecked,,,Potency,uM,UO_0000065,25.929
58867,inconclusive,5405362,CHEMBL1737994,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504444]",F,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,Potency,nM,16360.1,CHEMBL612545,,Unchecked,,,Potency,uM,UO_0000065,16.3601
58868,,6149679,CHEMBL1764320,Antiviral activity against 0.05 MOI Human immunodeficiency virus 1 NL4.3 infected in human CEM cells expressing green fluorescent protein assessed as p24 antigen production at 0.29 uM measured 7 days post infection by ELISA,F,BAO_0000201,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1759861,Eur J Med Chem,2011.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://qudt.org/vocab/unit#Percent,1413335,=,1,1,=,Inhibition,%,66.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676.0,,INH,%,UO_0000187,66.0
58869,,6149698,CHEMBL1764652,Inhibition of Human immunodeficiency virus 1 NL4.3 reverse transcriptase activity at 20 ug/ml,B,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1759861,Eur J Med Chem,2011.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://qudt.org/vocab/unit#Percent,1413335,=,1,1,=,Inhibition,%,94.0,CHEMBL247,Human immunodeficiency virus 1,Human immunodeficiency virus type 1 reverse transcriptase,11676.0,,INH,%,UO_0000187,94.0
58870,,6149702,CHEMBL1764653,Inhibition of Human immunodeficiency virus 1 NL4.3 reverse transcriptase activity,B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1759861,Eur J Med Chem,2011.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,1,http://www.openphacts.org/units/MicrogramPerMilliliter,1413335,=,1,1,=,IC50,ug.mL-1,100.0,CHEMBL247,Human immunodeficiency virus 1,Human immunodeficiency virus type 1 reverse transcriptase,11676.0,,IC50,ug ml-1,UO_0000274,100.0
58871,,6155573,CHEMBL1764263,Antiviral activity against 0.05 MOI Human immunodeficiency virus 1 NL4.3 infected in human CEM cells expressing green fluorescent protein assessed as p24 antigen production measured 7 days post infection by ELISA,F,BAO_0000188,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1759861,Eur J Med Chem,2011.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1413335,=,1,1,=,EC50,nM,130.0,CHEMBL378,Human immunodeficiency virus 1,Human immunodeficiency virus 1,11676.0,,EC50,uM,UO_0000065,0.13
58872,,6168791,CHEMBL1767832,Inhibition of electric eel Acetylcholinesterase,B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1765080,Bioorg Med Chem,2011.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,1,http://www.openphacts.org/units/Nanomolar,1416884,=,1,1,=,IC50,nM,374.0,CHEMBL4078,Electrophorus electricus,Acetylcholinesterase,8005.0,,IC50,uM,UO_0000065,0.374
58873,,6168809,CHEMBL1767833,Inhibition of equine serum Butyrylcholinesterase,B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1765080,Bioorg Med Chem,2011.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,1,http://www.openphacts.org/units/Nanomolar,1416884,=,1,1,=,IC50,nM,18200.0,CHEMBL5077,Equus caballus,Butyrylcholinesterase,9796.0,,IC50,uM,UO_0000065,18.2
58874,,6168827,CHEMBL1767831,Ratio of IC50 for equine serum Butyrylcholinesterase to IC50 for electric eel Acetylcholinesterase,B,BAO_0000179,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1765080,Bioorg Med Chem,2011.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1416884,=,1,0,=,Ratio IC50,,48.6,CHEMBL612545,,Unchecked,,,Ratio IC50,,,48.6
58875,,6168846,CHEMBL1767829,Inhibition of amyloid-beta (1 to 42) aggregation at 20 uM after 48 hrs by fluorescence analysis using thioflavin T,B,BAO_0000201,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1765080,Bioorg Med Chem,2011.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://qudt.org/vocab/unit#Percent,1416884,=,1,1,=,Inhibition,%,36.3,CHEMBL612545,,Unchecked,,,INH,%,UO_0000187,36.3
58876,Active,6195984,CHEMBL1775679,Downregulation of Scd2 mRNA expression in rat A10 cells at 30 uM after 24 hrs by quantitative RT-PCR analysis,F,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1772972,J Nat Prod,2011.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1421166,,1,0,,Activity,,,CHEMBL614513,Rattus norvegicus,A10,10116.0,,Activity,,,
58877,Active,6195987,CHEMBL1775680,Down regulation of Prim2 mRNA expression in rat A10 cells at 30 uM after 24 hrs by quantitative RT-PCR analysis,F,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1772972,J Nat Prod,2011.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1421166,,1,0,,Activity,,,CHEMBL614513,Rattus norvegicus,A10,10116.0,,Activity,,,
58878,Active,6195990,CHEMBL1775681,Downregulation of Impk mRNA expression in rat A10 cells at 30 uM after 24 hrs by quantitative RT-PCR analysis,F,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1772972,J Nat Prod,2011.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1421166,,1,0,,Activity,,,CHEMBL614513,Rattus norvegicus,A10,10116.0,,Activity,,,
58879,Not Active,6196001,CHEMBL1775739,Upregulation of Rgc32 mRNA expression in rat A10 cells at 3 to 30 uM after 12 hrs by quantitative RT-PCR analysis,F,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1772972,J Nat Prod,2011.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1421166,,1,0,,Activity,,,CHEMBL614513,Rattus norvegicus,A10,10116.0,,Activity,,,
58880,Active,6233969,CHEMBL1789905,"NOVARTIS: Antimalarial liver stage activity measured as a greater than 50% reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells at 10uM compound concentration, determined by immuno-fluorescence.",F,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1789904,Science,2011.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1432136,,3,0,,Activity,,,CHEMBL612889,Plasmodium yoelii,Plasmodium yoelii,5861.0,,Activity,,,
58881,,6234139,CHEMBL1789906,"NOVARTIS: Antimalarial liver stage activity measured as reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells by immuno-fluorescence, and median schizont size at 10uM compound concentration",F,BAO_0000190,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1789904,Science,2011.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1432136,=,3,1,=,IC50,nM,548.0,CHEMBL612889,Plasmodium yoelii,Plasmodium yoelii,5861.0,,IC50,uM,UO_0000065,0.548
58882,active,6550855,CHEMBL1794345,"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]",F,BAO_0000186,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,Potency,nM,65.7,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Potency,uM,UO_0000065,0.0657
58883,active,6707035,CHEMBL1794345,"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]",F,BAO_0000186,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,Potency,nM,147.2,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Potency,uM,UO_0000065,0.1472
58884,inconclusive,6816502,CHEMBL1794424,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],F,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,Potency,nM,79432.8,CHEMBL6035,Rattus norvegicus,"Thioredoxin reductase 1, cytoplasmic",10116.0,,Potency,uM,UO_0000065,79.4328
58885,active,6851299,CHEMBL1794496,"PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435005, AID435007]",F,BAO_0000186,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1264003,=,7,1,=,AC50,nM,3252.0,CHEMBL613545,Rattus norvegicus,INS1,10116.0,,AC50,uM,UO_0000065,3.252
58886,inconclusive,7043979,CHEMBL1794512,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Cell Surface uPA Generation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493178],F,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,Potency,nM,6309.6,CHEMBL612545,,Unchecked,,,Potency,uM,UO_0000065,6.3096
58887,inconclusive,7054771,CHEMBL1794512,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Cell Surface uPA Generation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493178],F,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,Potency,nM,4466.8,CHEMBL612545,,Unchecked,,,Potency,uM,UO_0000065,4.4668
58888,active,7135343,CHEMBL1794580,"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]",F,BAO_0000186,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,Potency,nM,233.2,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Potency,uM,UO_0000065,0.2332
58889,active,7138137,CHEMBL1794580,"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]",F,BAO_0000186,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,Potency,nM,207.9,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,Potency,uM,UO_0000065,0.2079
58890,inconclusive,7438164,CHEMBL1794375,"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",B,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,Potency,nM,14581.0,CHEMBL612545,,Unchecked,,,Potency,uM,UO_0000065,14.581
58891,inconclusive,7527924,CHEMBL1794375,"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",B,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,Potency,nM,14581.0,CHEMBL612545,,Unchecked,,,Potency,uM,UO_0000065,14.581
58892,inconclusive,7557516,CHEMBL1794440,PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],F,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,Potency,nM,89125.1,CHEMBL6035,Rattus norvegicus,"Thioredoxin reductase 1, cytoplasmic",10116.0,,Potency,uM,UO_0000065,89.1251
58893,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599397,CHEMBL1909084,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58894,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599398,CHEMBL1909084,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58895,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599399,CHEMBL1909085,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL319,Rattus norvegicus,Alpha-1a adrenergic receptor,10116.0,,IC50,,,
58896,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599400,CHEMBL1909085,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL319,Rattus norvegicus,Alpha-1a adrenergic receptor,10116.0,,Ki,,,
58897,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599401,CHEMBL1909086,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL315,Rattus norvegicus,Alpha-1b adrenergic receptor,10116.0,,IC50,,,
58898,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599402,CHEMBL1909086,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL315,Rattus norvegicus,Alpha-1b adrenergic receptor,10116.0,,Ki,,,
58899,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599419,CHEMBL1909095,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),B,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL2622,Rattus norvegicus,Aldose reductase,10116.0,,IC50,,,
58900,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599420,CHEMBL1909095,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),B,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL2622,Rattus norvegicus,Aldose reductase,10116.0,,Ki,,,
58901,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599423,CHEMBL1909097,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",B,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58902,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599424,CHEMBL1909097,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",B,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58903,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599425,CHEMBL1909098,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58904,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599426,CHEMBL1909098,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58905,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599427,CHEMBL1909099,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),B,BAO_0000190,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58906,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599428,CHEMBL1909099,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),B,BAO_0000192,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58907,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599433,CHEMBL1909102,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58908,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599434,CHEMBL1909102,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58909,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599435,CHEMBL1909103,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58910,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599436,CHEMBL1909103,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58911,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599437,CHEMBL1909121,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58912,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599438,CHEMBL1909121,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58913,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600823,CHEMBL1909147,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58914,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600824,CHEMBL1909147,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58915,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600825,CHEMBL1909148,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58916,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600826,CHEMBL1909148,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58917,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600827,CHEMBL1909149,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58918,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600828,CHEMBL1909149,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58919,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600831,CHEMBL1909151,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58920,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600832,CHEMBL1909151,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58921,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600833,CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58922,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600834,CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58923,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600835,CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58924,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600836,CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58925,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600837,CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58926,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600838,CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58927,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600839,CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,IC50,,,
58928,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600840,CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,Ki,,,
58929,,7600847,CHEMBL1909159,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,IC50,nM,1278.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,1.278
58930,,7600848,CHEMBL1909159,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,Ki,nM,852.0,CHEMBL612545,,Unchecked,,,Ki,uM,UO_0000065,0.852
58931,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600849,CHEMBL1909160,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL5486,Rattus norvegicus,Insulin receptor,10116.0,,IC50,,,
58932,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600850,CHEMBL1909160,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL5486,Rattus norvegicus,Insulin receptor,10116.0,,Ki,,,
58933,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600851,CHEMBL1909161,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58934,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600852,CHEMBL1909161,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58935,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600853,CHEMBL1909162,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58936,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600854,CHEMBL1909162,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58937,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600855,CHEMBL1909163,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),B,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL1909043,Cavia porcellus,Leukotriene C4 synthase,10141.0,,IC50,,,
58938,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600856,CHEMBL1909163,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),B,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL1909043,Cavia porcellus,Leukotriene C4 synthase,10141.0,,Ki,,,
58939,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600859,CHEMBL1909165,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),B,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL4358,Oryctolagus cuniculus,Arachidonate 15-lipoxygenase,9986.0,,IC50,,,
58940,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600860,CHEMBL1909165,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),B,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL4358,Oryctolagus cuniculus,Arachidonate 15-lipoxygenase,9986.0,,Ki,,,
58941,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600883,CHEMBL1909177,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58942,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600884,CHEMBL1909177,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58943,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600885,CHEMBL1909178,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",B,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL3048,Rattus norvegicus,"Nitric-oxide synthase, brain",10116.0,,IC50,,,
58944,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600886,CHEMBL1909178,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",B,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL3048,Rattus norvegicus,"Nitric-oxide synthase, brain",10116.0,,Ki,,,
58945,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600895,CHEMBL1909183,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58946,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600896,CHEMBL1909183,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58947,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600897,CHEMBL1909184,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58948,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600898,CHEMBL1909184,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58949,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600899,CHEMBL1909185,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58950,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600900,CHEMBL1909185,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58951,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600905,CHEMBL1909188,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),B,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58952,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600906,CHEMBL1909188,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),B,BAO_0000192,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58953,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600907,CHEMBL1909189,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58954,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600908,CHEMBL1909189,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58955,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600911,CHEMBL1909191,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),B,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL1909044,Bos taurus,Progesterone receptor,9913.0,,IC50,,,
58956,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600912,CHEMBL1909191,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),B,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL1909044,Bos taurus,Progesterone receptor,9913.0,,Ki,,,
58957,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600913,CHEMBL1909192,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",B,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL4074,Oryctolagus cuniculus,Angiotensin-converting enzyme,9986.0,,IC50,,,
58958,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600914,CHEMBL1909192,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",B,BAO_0000192,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL4074,Oryctolagus cuniculus,Angiotensin-converting enzyme,9986.0,,Ki,,,
58959,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602278,CHEMBL1909208,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58960,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602279,CHEMBL1909208,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58961,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602280,CHEMBL1909209,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL273,Rattus norvegicus,Serotonin 1a (5-HT1a) receptor,10116.0,,IC50,,,
58962,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602281,CHEMBL1909209,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL273,Rattus norvegicus,Serotonin 1a (5-HT1a) receptor,10116.0,,Ki,,,
58963,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602282,CHEMBL1909210,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL3459,Rattus norvegicus,Serotonin 1b (5-HT1b) receptor,10116.0,,IC50,,,
58964,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602283,CHEMBL1909210,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL3459,Rattus norvegicus,Serotonin 1b (5-HT1b) receptor,10116.0,,Ki,,,
58965,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602290,CHEMBL1909106,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58966,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602291,CHEMBL1909106,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58967,,7602292,CHEMBL1909107,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,IC50,nM,2222.0,CHEMBL5017,Cavia porcellus,Serotonin 4 (5-HT4) receptor,10141.0,,IC50,uM,UO_0000065,2.222
58968,,7602293,CHEMBL1909107,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,Ki,nM,370.0,CHEMBL5017,Cavia porcellus,Serotonin 4 (5-HT4) receptor,10141.0,,Ki,uM,UO_0000065,0.37
58969,,7602300,CHEMBL1909111,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,IC50,nM,95.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,0.095
58970,,7602301,CHEMBL1909111,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1539543,=,15,1,=,Ki,nM,59.0,CHEMBL612545,,Unchecked,,,Ki,uM,UO_0000065,0.059
58971,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602302,CHEMBL1909112,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58972,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602303,CHEMBL1909112,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58973,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602308,CHEMBL1909115,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,IC50,,,
58974,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602309,CHEMBL1909115,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,Ki,,,
58975,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602312,CHEMBL1909117,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",B,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
58976,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602313,CHEMBL1909117,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",B,BAO_0000192,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1909046,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1539543,,15,0,,Ki,,,CHEMBL612545,,Unchecked,,,Ki,,,
58977,,7968898,CHEMBL1931047,Inhibition of electric eel AChE using acetylcholine chloride as substrate preincubated for 15 mins by Ellman's method,B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1926506,Bioorg Med Chem,2011.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,1,http://www.openphacts.org/units/Nanomolar,1563712,=,1,1,=,IC50,nM,374.0,CHEMBL4078,Electrophorus electricus,Acetylcholinesterase,8005.0,,IC50,uM,UO_0000065,0.374
58978,,7968915,CHEMBL1931048,Inhibition of equine serum BuChE using butyrylthiocholine chloride as substrate preincubated for 15 mins by Ellman's method,B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1926506,Bioorg Med Chem,2011.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,1,http://www.openphacts.org/units/Nanomolar,1563712,=,1,1,=,IC50,nM,18200.0,CHEMBL5077,Equus caballus,Butyrylcholinesterase,9796.0,,IC50,uM,UO_0000065,18.2
58979,,7968932,CHEMBL1931049,Selectivity ratio of IC50 for equine serum BuChE to IC50 for electric eel AChE,B,BAO_0000179,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1926506,Bioorg Med Chem,2011.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1563712,=,1,0,=,Ratio IC50,,48.6,CHEMBL612545,,Unchecked,,,Ratio IC50,,,48.6
58980,Not Determined,7968946,CHEMBL1931050,Inhibition of equine serum BuChE using acetylcholine as substrate preincubated for 15 mins by Ellman's method,B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1926506,Bioorg Med Chem,2011.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1563712,,1,0,,IC50,,,CHEMBL5077,Equus caballus,Butyrylcholinesterase,9796.0,,IC50,,,
58981,,7969853,CHEMBL1931051,Antioxidant activity assessed as trolox equivalent of APPH-induced radical scavenging activity at 0.5 to 10 uM measured every 60 sec for 4 hrs by ORAC fluorescence assay relative to trolox,F,BAO_0000193,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1926506,Bioorg Med Chem,2011.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1563712,=,1,0,=,Ratio,,0.4,CHEMBL3879801,,NON-PROTEIN TARGET,,,Ratio,,,0.4
58982,,7969868,CHEMBL1931052,Inhibition of self-mediated amyloid beta (1 to 42) aggregation at 20 uM after 48 hrs by thioflavin T fluorescence assay,B,BAO_0000201,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1926506,Bioorg Med Chem,2011.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://qudt.org/vocab/unit#Percent,1563712,=,1,1,=,Inhibition,%,36.3,CHEMBL612545,,Unchecked,,,INH,%,UO_0000187,36.3
58983,,10834498,CHEMBL2013296,Binding affinity to calf thymus DNA in presence of citrate-phosphate buffer at pH 7 by spectrophotometry,B,BAO_0000192,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL2010762,Bioorg Med Chem,2012.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1631759,=,1,1,=,Ki,nM,36400.0,CHEMBL345,,Nucleic Acid,,,Ki,10'-5/M,UO_0000065,3.64
58984,,10834502,CHEMBL2013297,Binding affinity to calf thymus DNA in presence of citrate-phosphate buffer at pH 7 by spectrofluorimetry,B,BAO_0000192,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL2010762,Bioorg Med Chem,2012.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1631759,=,1,1,=,Ki,nM,36400.0,CHEMBL345,,Nucleic Acid,,,Ki,10'-5/M,UO_0000065,3.64
58985,Active,10834510,CHEMBL2013298,Binding affinity to calf thymus DNA in citrate-phosphate buffer at pH 7 by circular dichroism spectral analysis,B,BAO_0000375,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL2010762,Bioorg Med Chem,2012.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1631759,,1,0,,Activity,,,CHEMBL345,,Nucleic Acid,,,Activity,,,
58986,Active,10834516,CHEMBL2013300,Binding affinity to calf thymus DNA in citrate-phosphate buffer at pH 7 assessed as change in viscosity by hydrodynamic method,B,BAO_0000375,BAO_0000225,nucleic acid format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL2010762,Bioorg Med Chem,2012.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1631759,,1,0,,Activity,,,CHEMBL345,,Nucleic Acid,,,Activity,,,
58987,Not Active,10869675,CHEMBL2026480,Antimycobacterial activity against drug-susceptible Mycobacterium tuberculosis H37Rv measured 24 hrs post dose by microplate alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL2021893,Eur J Med Chem,2012.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1639801,,1,0,,MIC,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,,,
58988,inconclusive,11375969,CHEMBL2114861,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen. (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,Potency,nM,19952.6,CHEMBL612545,,Unchecked,,,Potency,uM,UO_0000065,19.9526
58989,inconclusive,11507761,CHEMBL2114775,PubChem BioAssay. qHTS Assay for Inhibitors of Hepatitis C Virus (HCV). (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,Potency,nM,7079.5,CHEMBL612545,,Unchecked,,,Potency,uM,UO_0000065,7.0795
58990,inconclusive,11533531,CHEMBL2114775,PubChem BioAssay. qHTS Assay for Inhibitors of Hepatitis C Virus (HCV). (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,Potency,nM,3162.3,CHEMBL612545,,Unchecked,,,Potency,uM,UO_0000065,3.1623
58991,active,11655698,CHEMBL2114782,PubChem BioAssay. qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay. (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1010458,,7,1,,Potency,nM,9439.2,CHEMBL612545,,Unchecked,,,Potency,uM,UO_0000065,9.4392
58992,inconclusive,11974944,CHEMBL2114836,PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,Potency,nM,35481.3,CHEMBL2146310,Human immunodeficiency virus 1,Aberrant vpr protein,11676.0,,Potency,uM,UO_0000065,35.4813
58993,inconclusive,11993220,CHEMBL2114836,PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,Potency,nM,3548.1,CHEMBL2146310,Human immunodeficiency virus 1,Aberrant vpr protein,11676.0,,Potency,uM,UO_0000065,3.5481
58994,active,12015666,CHEMBL2114840,PubChem BioAssay. qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay. (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL1201862,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1010458,,7,1,,Potency,nM,21131.7,CHEMBL612545,,Unchecked,,,Potency,uM,UO_0000065,21.1317
58995,,12072533,CHEMBL2162818,Increase in AMPKalpha phosphorylation in human HepG2 cells at 10 uM after 4 hrs by Western blot analysis relative to untreated control relative to total AMPKalpha level,B,BAO_0000179,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL2157930,Bioorg Med Chem,2012.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1735379,<=,1,0,<=,FC,,3.2,CHEMBL612545,,Unchecked,,,FC,,,3.2
58996,Active,12072540,CHEMBL2162816,Increase in AMPKalpha phosphorylation in human HepG2 cells at 10 uM after 4 hrs by Western blot analysis relative to untreated control,B,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL2157930,Bioorg Med Chem,2012.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,,1735379,,1,0,,Activity,,,CHEMBL612545,,Unchecked,,,Activity,,,
58997,,12096404,CHEMBL2166033,Inhibition of amyloid beta (1 to 40) aggregation assessed as induction of disaggregation treated 45 mins after formation of aggregates by thioflavin T fluorescence method,B,BAO_0000190,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL2163249,Bioorg Med Chem,2012.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1736119,=,1,1,=,IC50,nM,105900.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,105.9
58998,,12096408,CHEMBL2166028,Inhibition of HFIP-induced amyloid beta (1 to 40) aggregation after 45 mins by thioflavin T fluorescence method,B,BAO_0000190,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL2163249,Bioorg Med Chem,2012.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1736119,=,1,1,=,IC50,nM,43840.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,43.84
58999,,12096419,CHEMBL2166020,Inhibition of electric eel AChE by Ellman's method,B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],CHEMBL2163249,Bioorg Med Chem,2012.0,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,0,http://www.openphacts.org/units/Nanomolar,1736119,=,1,1,=,IC50,nM,2740.0,CHEMBL4078,Electrophorus electricus,Acetylcholinesterase,8005.0,,IC50,uM,UO_0000065,2.74
